Posttraumatic stress in adolescents with HIV and its relationship with treatment adherence: the role of health beliefs by Weinberger, Beverley Slome
  
  
 
 
 
 
Posttraumatic Stress in Adolescents with HIV and its Relationship with Treatment 
Adherence: The Role of Health Beliefs  
 
A Thesis Proposal 
Submitted to the Faculty  
of  
Drexel University 
by  
Beverley Slome Weinberger 
in partial fulfillment of the  
requirements for the degree 
of 
Doctor of Philosophy 
April 2010 
  
  
 
 
 
 
 
 
 
 
 
 
© Copyright 2010 
Beverley Slome Weinberger.   ALL RIGHTS RESERVED. 
 
 
 
ii 
 
  
Dedications 
 
To the light of my life, Noa Talya, for showing that miracles are possible every day.
iii 
 
  
Acknowledgements 
 
 I find it almost impossible to adequately acknowledge and thank my mentor, Dr. 
Lamia P. Barakat.  Over and above the guidance, support, and time she so generously 
gave towards this project, she has served as a model and inspiration for the type of 
professional I aspire to be.   Lamia you have had an extraordinary influence on my 
personal and professional development   Thank you for your patience, your 
encouragement, and for believing in me.   
 Thank you to my dissertation committee for their helpful critiques and their 
support of this project.  Dr. Jacqueline D. Kloss contributed significant time and 
assistance in assuming the position of chair.  I am very grateful to have had the privilege 
of her expertise throughout my time in graduate school.  Dr. Jerilynn Radcliffe’s 
important work with youth with HIV and other chronic illness groups has been the 
impetus for this project.  Dr. Foster’s sponsorship of this project and expert knoweldge 
regarding clinical HIV has been invaluable. Dr. Meredith Lutz Stehl has been an 
inspiration to me both as a fellow student and now as a mentor.   Thank you all for your 
contributions to my project. 
 I must single out fellow students, Lauren Daniel and Sarah Horsey for their 
tireless efforts in collecting the data for this project.  I literally could not have completed 
this project without your help and it gave me peace of mind to know that this project was 
in such good hands while I was away.  I have to also thank Keren Brooks for generously 
giving of her time in providing assistance with statistics.
iv 
 
  
 I am blessed to have a loving family who has provided support in so many 
capacities towards completion of this dissertation.  My husband, Leor, has constantly 
encouraged me to reach my goals.  The dedication and passion that you show towards 
your own work has propelled me along my own path.  I could not have reached this 
milestone without you.  I love you.   Mom and Dad- I don’t think I can ever adequately 
thank you for all you have given me.   Mom, I would not have been able to complete this 
dissertation were it not for the many hours of your time you lovingly gave up to help with 
Noa.  Even more than the physical help you provided, you have been a friend, a confidant 
and a source of constant encouragement.  Dad, I hope that in aspiring to be the honorable, 
hardworking, and loving parent you are that I will somehow be able to demonstrate my 
gratitude for all you have done and continue to do for me.   Thank you for motivating me 
to get this completed!  To Susan and Alex, my parents-in-law, your love and 
encouragement has been so much appreciated.  To my brother, sister, and sister-in-law, 
thank you for always keeping me laughing, especially when the going got tough!  
Although I’m your “big sister” it is I who have learned so much from the two of you.  
And to my daughter Noa, the light of my life- thank you for letting mommy have time 
away from you to finish this project.    Being your mother has been the most beautiful 
and meaningful experience of my life.  I hope that I will be able to return to you even a 
fraction of the blessings and joy that you have brought to my life.     
 Finally I wish to thank and acknowledge the patients of the Special Immunology 
Clinic for their participation in this study.  You entrusted me with a piece of your lives 
and I have been truly humbled.    Thank you for your honesty and your time in 
participation.   I hope that this work will in some way honor you and your efforts.  
v 
 
  
Table of Contents 
 
LIST OF TABLES........................................................................................................... viii 
ABSTRACT .......................................................................................................................ix 
CHAPTER 1. INTRODUCTION........................................................................................1 
CHAPTER 2. LITERATURE REVIEW.............................................................................4 
HIV Background..................................................................................................................4 
     Routes of Transmission ..................................................................................................4 
     The Transmission and Prevalence of HIV in Children and Adolescents .......................5 
     Clinical Manifestations...................................................................................................7 
     Neurocognitive Development .........................................................................................8 
Treatment: Antiretroviral Therapies ....................................................................................9 
Treatment adherence..........................................................................................................12 
      Psychosocial Stressors. ................................................................................................15 
      PTSD in Youth with HIV ............................................................................................19 
      PTSD in Chronic Illness ..............................................................................................23 
      Pediatric Medical Traumatic Stress .............................................................................25 
      PTSD in Adults with HIV............................................................................................26 
      PTSD and Adherence ..................................................................................................28 
      Other Factors Associated with Adherence ..................................................................32 
      Health Belief Model and Adherence ...........................................................................34  
Purpose of the Present Study .............................................................................................37 
Aims and Hypotheses ........................................................................................................40
vi 
 
  
 
CHAPTER 3. METHODS.................................................................................................44 
Participant Recruitment .....................................................................................................44 
Participant Description ......................................................................................................45 
      Total Sample................................................................................................................45 
      Perinatal Group............................................................................................................46 
      Behavioral Group.........................................................................................................47 
      Comparability of the Two Samples .............................................................................47 
Measures ............................................................................................................................48 
      Demographic and Adherence Variables ......................................................................48 
      Life Stressors ...............................................................................................................49 
      Posttraumatic Stress.....................................................................................................50 
      Health Locus of Control Data......................................................................................53 
      Debriefing Interview....................................................................................................54 
Procedure ...........................................................................................................................54 
Data Analysis Plan.............................................................................................................55 
      Hypothesis I .................................................................................................................55 
      Hypothesis II................................................................................................................56 
      Hypothesis III ..............................................................................................................56 
      Follow-Up Analyses ....................................................................................................56 
CHAPTER 4. RESULTS...................................................................................................58 
Preliminary Analyses.........................................................................................................58 
      Power Analyses ...........................................................................................................58
vii 
 
  
 
      Sampling Distribution of Variables .............................................................................58 
      Correlations Between Demographic and Adherence Variables ..................................58 
      Correlations Among Adherence Variables ..................................................................60 
Description of Study Variables..........................................................................................60 
Examination of Hypotheses ...............................................................................................61  
      Hypothesis I .................................................................................................................61 
      Hypothesis II................................................................................................................62 
      Hypothesis III ..............................................................................................................62 
      Exploratory Analyses...................................................................................................63 
CHAPTER 5. DISCUSSION.............................................................................................65 
Review of Results ..............................................................................................................66 
      Posttraumatic Stress.....................................................................................................66 
      Posttraumatic Stress and Adherence............................................................................67 
      Internal Health Locus of Control .................................................................................68 
Limitations.........................................................................................................................69 
Clinical Implications and Future Research Directions .....................................................73 
Conclusions........................................................................................................................77 
LIST OF REFERENCES...................................................................................................78 
APPENDIX A. MEASURES ............................................................................................97 
VITA................................................................................................................................118 
 
viii 
 
  
LIST OF TABLES 
1. Preliminary Analyses for Transmission Group Equality on Relevant Demographic       
    Variables .......................................................................................................................90 
2. Adherence-Related Variables ........................................................................................91 
3. Means and Standard Deviations on Psychological Variables........................................92 
4. Correlations between Adherence Variables, PTSD Symptom Severity, &  
    Internal Health Locus of Control ..................................................................................93 
5. Partial Correlations Controlling for Internal Health Locus of Control .........................94 
 
 
ix 
 
  
Abstract 
Posttraumatic Stress in Adolescents with HIV and its Relationship with Treatment 
Adherence: The Role of Health Beliefs 
Beverley Slome Weinberger 
Jacqueline D. Kloss, Ph.D., Chair 
Lamia P. Barakat, Ph.D., Cochair 
 
 
 
 Objective: The introduction of HAART has led to increased life expectancy 
among youth with HIV, however, it poses challenges including complex drug regimens 
that require strict adherence by patients.  Treatment adherence by youth with HIV is 
generally considered suboptimal, although adherence reports vary by the method of 
assessment used.  Given the prevailing problem of treatment adherence in this population, 
research has focused on identifying factors contributing to nonadherence.  Research on 
adults with HIV and children with other chronic illnesses suggests that posttraumatic 
stress disorder (PTSD), posttraumatic stress symptoms (PTSS), and health beliefs may be 
important factors relating to nonadherence.  This study investigated the prevalence of 
PTSS in a sample of adolescents and young adults perinatally and behaviorally-infected 
with HIV.  The relationship of PTSS with treatment adherence and the role of internal 
health locus of control (IHLC) were explored.  Methods:  Twenty-eight participants (M 
age = 17.14, SD = 3.05; range = 12-22) recruited from a pediatric immunology clinic 
completed measures of life events, posttraumatic stress symptoms, and health locus of 
control.  Measures of treatment adherence used included: viral load count, CD4 count, 
and provider ratings of adherence.  Results:  Findings revealed relatively good adherence 
levels and low disease severity among the sample.   Eighty-two percent of participants 
reported experiencing a least one HIV-related traumatic event and 75% of participants 
reported experiencing at least one non-HIV related traumatic event.  Posttraumatic 
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stress symptom severity scores fell in the moderate range of severity for both HIV-related 
and general traumas.  No differences were found in trauma scores based on mode of 
transmission or developmental level (adolescents vs. young adults).   Provider ratings of 
adherence and viral load were correlated with PTSS.  IHLC did not demonstrate a 
significant indirect effect on the relationship between treatment adherence and PTSS.  
Discussion:  Difficulties in recruitment for this study point to the many stressors facing 
youth with HIV and the barriers to successful recruitment of ethnic minority participants 
in research.  Findings highlight the need to address psychosocial problems among youth 
with HIV, in particular posttraumatic stress, in order to improve treatment adherence and 
health outcomes.  Further research is needed to clarify the role of health beliefs as they 
relate to health-promoting behaviors in this population.  Additionally, future research is 
needed to establish standardized, valid, reliable, and cost-effective measures of 
adherence.   Barriers to recruitment and retention of ethnic minority participants must 
also be addressed.  Findings are limited by small sample size, low power, and restriction 
of range in data.   
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CHAPTER 1. INTRODUCTION 
The past two decades have witnessed dramatic changes in the state of pediatric 
HIV in the United States.  Advancements in treatment, specifically highly active 
antiretroviral therapy (HAART), have improved survival rates, decreased vertical 
transmission, and resulted in better overall management of symptoms and quality of life 
(Armstrong, Willen, & Sorgen, 2003).  Consequently, HIV infection, previously viewed 
as a fatal disease, is now considered a chronic illness, and a stressor to which children 
and adolescents must adapt (Armstrong et al., 2003; Bachanas et al., 2001; Lewis, 2001).   
Although the introduction of HAART has led to improved survival, it also poses 
additional challenges, including increasingly complex drug regimens that require strict 
adherence by patients (Chesney, 2000).  Problems in treatment adherence in pediatric 
HIV have been widely documented and are strongly correlated with HIV morbidity and 
mortality (Murphy, Moscicki, Vermund, & Muenz, 2000).  Inadequate adherence to 
HAART causes an increase in viral load and resistance to drug therapy.  Research on 
adult HIV populations has recently focused on identifying factors associated with 
reduced adherence.   Patient factors, such as health beliefs and psychosocial difficulties 
have been identified as correlates of adherence.  However, less is known about adherence 
in children and adolescents with HIV.   
In addition to problems with adherence, children and adolescents with HIV and 
their families face a number of disease-related stressors including: complex treatment 
regimes, interaction with multiple medical providers, disruption of daily activities, 
developmental delays, and premature death (Lewis, Haiken, & Hoyt, 1994).  
Furthermore, families affected by HIV are overwhelmingly ethnic minorities, and often 
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face other issues relating to poverty, low socioeconomic status (SES), reduced access to 
medical care, and limited social and educational resources (Lewis, 2001).  In addition, 
HIV/AIDS continues to carry the burdens of secrecy, social stigma and isolation (Brown, 
Lourie, & Pao, 2000; Lewis, 2001).    
Researchers investigating numerous challenges facing individuals living with HIV 
have focused on the issue of psychosocial adaptation.  Most of the research regarding 
adaptation to HIV has been conducted on adults living with HIV and has revealed 
surprisingly high rates of Posttraumatic Stress Disorder (PTSD) and posttraumatic stress 
symptoms (PTSS) (Brief et al., 2004; Delahanty, Bogart, & Figler, 2004).  The research 
has examined relationships between high rates of traumatic experiences within the HIV 
population (such as childhood abuse, sexual assault and other victimization stressors) and 
PTSD (Allers & Benjack, 1991; Brief et al., 2004).   Research indicates that problems in 
adaptation such as behavioral and emotional disorders may contribute to health outcomes.  
Specifically, the existing literature regarding PTSD symptomatology in adults with HIV 
suggests that PTSD and PTSS may be associated with reduced treatment adherence 
(Cohen, Alfonso, Hoffman, Milau, & Carrera, 2001; Delahanty et al., 2004).  
While one published report has documented the prevalence of PTSS in 
behaviorally-infected adolescents (Radcliffe, Tanney, & Rudy, 2006), to date, no 
published studies have investigated the prevalence of PTSD in perinatally-infected 
adolescents living with HIV.  Given the high rates of non-adherence in this population, 
(Armstrong et al., 2003; Reisner et al., 2009b) and its impact on treatment resistance and 
survival, this represents a significant gap in the existing psychosocial literature.  The 
following research proposal aims to explore the rates of PTSD and PTSS in youth with 
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HIV and its possible relationship with treatment adherence. The impact of health beliefs, 
specifically, internal health locus of control orientation, will also be explored.  A review 
of the current epidemiological data surrounding HIV infection in the US is provided, as 
well as a discussion of psychosocial adjustment in children and adolescents with HIV.  
The prevalence of PTSD in medical populations is discussed as well as its impact on 
health outcomes. Finally, rationale and proposed hypotheses for the study will be 
reviewed. 
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CHAPTER 2. LITERATURE REVIEW 
HIV Background 
 HIV-1 is a single-stranded RNA virus (retrovirus) which infects humans.  After 
infection of CD4+ T lymphocytes in the body, the virus incorporates, reverse transcribes 
its RNA into DNA and inserts this DNA copy into the DNA of the T cell (Fields, Knipe, 
& Howley, 2001).  The virus then replicates, destroys the T-cell, and releases hundreds of 
infectious progeny virus particles into the body to continue the infection cycle.   As new 
T-cells are created by the body, they are continuously destroyed by HIV (Fields et al., 
2001).  The subsequent dramatic decline in the number of CD4+ T lymphocytes in the 
body impairs the body's ability to fight infections and certain cancers (Armstrong et al., 
2003).   When the number of these cells becomes low enough, opportunistic infections 
and neoplasms occur (Coffin, Hughes & Varmus, 1997).  
First recognized in 1981, acquired immunodeficiency syndrome (AIDS) is 
diagnosed when an adult or adolescent (age 13 or older) has both HIV infection and one 
of 26 conditions indicative of severe immunosuppression.   Children younger than 13 
may present with the same infections seen in adults but may additionally have severe 
forms of the typically common childhood bacterial infections, such as conjunctivitis (pink 
eye), ear infections, and tonsillitis (National Institute of Allergy and Infectious Diseases, 
2005).  A diagnosis of AIDS is also given to HIV-infected individuals when their CD4+ 
T-cell count falls below 200 cells/cubic millimeter (NIAID, 2005).   
Routes of transmission.  HIV can be transmitted by exposure to infected blood or 
blood products (such as through needle sharing between intravenous drug users, and 
rarely, through transfusions of infected blood), through sexual contact with an infected 
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person (either homosexual or heterosexual), or “vertically” from infected mother to infant 
either perinatally, intrapartum, or through breast milk (Coffin, et al., 1997; Read, 2003). 
  As yet, there is no scientific evidence to suggest that HIV can be transmitted by casual 
contact or via bites of insects such as mosquitoes (Coffin et al., 1997).    
The transmission and prevalence of HIV in children and adolescents.  According 
to the 2008 Report on the Global AIDS Epidemic by the Joint United Nations Programme 
on HIV/AIDS (UNAIDS), worldwide, in 2007 an estimated 33 million people had 
HIV/AIDS, and more than 2 million children under age 15 were infected.  Internationally, 
young people (ages 15 to 24) accounted for an estimated 45% of new HIV infections  
(UNAIDS, 2008). 
According to the CDC, by the end of 2006, an estimated 1.1million persons in the 
US were living with HIV/AIDS. Individuals aged 13-29 years had the highest rate of 
infection in any age group (34%)  (Hall et al., 2008), with a roughly 25% increase in 
diagnosed cases from 2003 in the same age group (CDC, 2008).  The CDC reported 
40,049 cases of AIDS in the US among the 13-24 age group in 2004 (CDC, 2008).  
The latest data available suggest HIV disproportionately affects minority groups. 
In 2006 in the US, of the 56,300 adolescents and adults newly infected with HIV, 45% of 
them were black individuals.  The rate of HIV diagnosis for African Americans was 8 
times the rate for whites.  The HIV incidence rate among Hispanics was almost 3 times 
higher than that among whites.  African American and Hispanic females are also 
disproportionately affected with their rate of infection higher by more than 19 and 5 times 
respectively than that of white women (Hall et al., 2008).  According to a 2007 CDC 
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report, although African American/Black children made up only 14% of the children in 
the US, they represented 73% of all pediatric AIDS cases (CDC, 2007).   
Most HIV-infected adolescents and young adults are behaviorally infected 
through sexual intercourse (Brown, Lourie, & Pao, 2000).  The majority of HIV-infected 
adolescent and young adult males are infected through sex with men. Adolescent and 
young adult females with HIV are primarily infected through heterosexual contact, with a 
small percent infected through injection drug use (NIAID, 2006).   Today, pediatric 
HIV is largely due to maternal transmission of the virus (Brown et al., 2000).  According 
to the 2007 Surveillance Report of the Centers for Disease Control and Prevention 
(CDC), 88% of children under age 13 with HIV/AIDS in 2007 acquired the infection via 
vertical transmission from their mothers (CDC, 2007).     
 Over the last decade in the US, the transmission rate of HIV has declined by 33 
percent (CDC, 2008).  Significant pharmacological treatment advancements as well as 
prevention efforts have led to this decline and have extended the life expectancies of 
individuals affected by HIV. Subsequently, many perinatally infected children live well 
into adulthood. According to the New York City Department of Health and Mental 
Hygiene, as of September 2004, 54% of children who were perinatally infected with HIV 
were 13 years or older (New York Department of Health and Mental Hygiene,  2005).  
Consequently, HIV is now viewed as a chronic illness rather than a disease indicative of 
impending death (Donenberg & Pao, 2005).  While transmission rates have dropped and 
life expectancies have been extended, the overall number of people living with HIV in 
the US continues to grow, creating increased opportunities for HIV transmission, 
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especially as medication adherence problems contribute to increased resistance and 
transmission of drug-resistance mutants of the disease. 
Clinical manifestations.  The detrimental effects of HIV on the functioning of the 
immune system allow for many opportunistic infections to occur.  In addition, the virus 
directly effects the development of the central nervous system (CNS), and can cause 
wasting syndromes, lung disease, and malignancies such as lymphoma. (Armstrong et al., 
2003).  While thousands of children with HIV were diagnosed with opportunistic 
infections as their presenting illness during the 1980’s and 1990’s (including 
Pneumocystis carinii pneumonia (PCP), cytomegalovirus (CMV) infection, 
Mycobacterium avium complex (MAC), and severe recurrent bacterial infections) the 
past decade has seen a dramatic decrease in the frequency of opportunistic infections 
among pediatric samples in the US (Abrams, 2000; CDC, 2009).   CNS encephalopathy 
is common in children in developing nations, but less common in children in the US due 
to available treatments (Armstrong et al., 2003). Herpes simplex viral infections, 
cytomegalovirus (CMV) infection, and varicella-zoster virus infections can also occur in 
children (Chadwick & Yogev, 1995).   Epstein-Barr viral infections (EBV) have been 
associated with non-Hodgkin’s lymphoma and several soft-tissue tumors (CDC, 2009).   
 While the clinical course of children and adolescents perinatally infected with 
HIV reflects long-term infection, adolescents and young adults behaviorally infected with 
HIV typically enter care asymptomatic but with moderate immune dysfunction 
(Futterman, Chabon, & Hoffman, 2000).  As reported by the cohort of behaviorally 
infected adolescents participating in the Reaching for Excellence in Adolescent Care and 
Health (REACH) study, 50% of HIV-infected females and over 75% of males had a CD4 
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count of less than 500 at study entry, and 27% of females, and 35% of males already met 
criteria for an AIDS diagnosis (Futterman et al., 2000; Rogers et al., 1998). 
Neurocognitive development.  The neurocognitive effects of HIV represents a 
major area of research, as the virus is known to release toxic substances in the brain and 
cause damage to the white matter, nerve tracks, and the integrity of the blood-brain 
barrier.   Additionally, repeated infections resulting from immuno-suppression can lead to 
vascular injury, hypoxia, metabolic abnormalities and sensory impairment.  Furthermore, 
older children and adolescents are at risk for secondary infections of the CNS due to 
immuno-compromised related infections such as toxoplasmosis, herpes simplex, and 
cytomegalovirus (CMV) (Armstrong et al., 2003).   
Research has indicated that variability exists in terms of patterns of neurological 
impairment and developmental impact of the disease.   For example, some findings 
indicate no differences in global intellectual ability between children with HIV and non-
infected controls (Cohen et al., 1991; Whitt et al., 1993), and others suggest that deficits 
in global intellectual functioning may exist in children with HIV (Belman, 1990).  
Additionally, the introduction of newer treatment regimens has changed the prevalence 
and severity of HIV’s neurocognitive effects.  For example, while patterns of CNS 
encephalopathy which impacted brain development were common during the early part 
of the HIV epidemic, they are now rarely seen in the US although they still present to a 
large degree among children in developing countries (Armstrong et al., 2003). 
 In addition to available medication, the specific pattern of neurocognitive deficits 
in a child or adolescent with HIV is dependent on a host of factors including HIV disease 
progression, prenatal exposure, the age of the child, the age at which HIV infection 
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occurs, timing/duration of CNS infection, poor nutrition, socioeconomic status, and 
treatment adherence (Armstrong et al., 2003; Brouwers et al., 1995; Pearson et al., 2000). 
Mode of transmission may also play a role, as it has been suggested that the 
neurocognitive impact of HIV in perinatally-infected individuals may be more severe 
than in adolescents or adults who are behaviorally infected, since the virus is typically 
introduced while neural development is occurring (Armstrong et al., 2003).  It is 
important to note that other psychosocial influences may also contribute to the cognitive 
functioning of children and adolescents with HIV including poverty, ethnic minority 
status, prenatal drug and alcohol exposure, reduced opportunities for stimulation, and 
presence of learning or developmental disabilities (Armstrong et al., 2003; Nozyce et al., 
2006).  However, it is often difficult to distinguish the contributions of these variables on 
the cognitive functioning of children with HIV (Brown, Lourie, & Pao, 2000).  
Treatment: Antiretroviral Therapies  
 Over the past two decades, the treatment and prevention of HIV has undergone 
several important changes (Havlir, 2008).  Currently, treatment is targeted sustained 
inhibition of viral replication, via blocking viral reverse transcriptase (RT) or protease,  
and subsequent protection and/or reconstitution of the immune system via pharmacologic 
intervention (Weller & Williams, 2001).  Medications for HIV fall into five main classes, 
which target different stages of viral replication.  The first group of drugs used to treat 
HIV infection was nucleoside RT inhibitors.  These drugs [nucleotide analogue RT 
inhibitors (NRTIs)], slow the spread of HIV in the body by interrupting the virus’ ability 
to reverse transcriptase (replicate itself) (NIAID, 2005).  Side effects associated with RT 
inhibitors include a decline in red or white blood cells, inflammation of the pancreas, and 
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nerve damage.  Non-nucleoside reverse transcriptase inhibitors which inhibit enzyme 
activity are also used (Weller & Williams, 2001).  Non-Nucleoside Reverse Transcriptase 
Inhibitors (NNRTI’s) work similarly to NRTI’s, but bind directly to RT to prevent it from 
making DNA.  A third class of drugs is protease inhibitors, which bind to the substrate 
site of the viral protease and interrupt viral replication.  When first introduced in 1996, 
these drugs were responsible for a significant decline in morbidity and mortality 
associated with HIV (Weller & Williams, 2001).  However, protease inhibitor regimens 
are sometimes associated with a high pill burden, and poor tolerability. Side effects of 
protease inhibitors can be severe and include gastrointestinal problems (nausea and 
diarrhea), severe allergic reactions, and local skin reactions. Entry/fusion inhibitors, a 
newer class of medication, interfere with the virus’s ability to fuse with the t-cell 
membrane and infect the cell (NIAID, 2005).  The newest class of drugs to be approved 
for treatment is integrase inhibitors. These drugs inhibit the final step of the provirus 
integration into the host genome by inhibiting strand transfer (Havlir, 2008).  Today, 
combination regimens incorporating integrase inhibitors represent promising intervention 
approaches for virologic suppression in individuals who have multiple class drug 
resistant HIV.   
While early treatment approaches included one of the above agents, treatments 
were generally ineffective at sustaining treatment effects over time (Armstrong et al., 
2003).   HAART is the current treatment approach which entails a combination of 
antiretroviral medications and protease inhibitors.  HAART regimens for children and 
adolescents with HIV may include two, three, or four medications administered up to as 
many as eight times per day (Armstrong et al., 2003).  Specific restrictions and changes 
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in food may be required as well with some regimens.  Since the widespread use of 
HAART began in 1997, there has been a dramatic decrease in HIV symptoms, as well as 
a reduction or elimination of detectable levels of the virus, and a subsequent increase in 
children’s quality of life (Armstrong et al., 2003).  Survival rates have been significantly 
impacted, as the risk of death was found to be lowered by 64% when HAART became 
commonly prescribed (Armstrong et al., 2003).   
The main challenges to prolonged, successful pharmacological treatment of HIV 
include the presence of long-lived latent reservoirs of infection which generally assure 
life-long persistence of the disease, as well as the ability of the virus to mutate and escape 
existing therapy regimes (Fields et al., 2001; Havlir, 2008; Weller & Williams, 2001).  
The paucity of ample clinical trials among children and adolescents with HIV as well as 
problems with adherence are also major obstacles to successful treatment (Donenberg & 
Pao, 2005).  Research indicates that adherence to antiretroviral therapy is strongly 
associated with health outcomes and negatively correlated to concurrent HIV-1 viral 
loads (Murphy et al., 2005).  However, successful treatment of HIV/AIDS through 
HAART medication regimens requires almost perfect adherence.  Even small changes in 
adherence can result in significant problems with virological control.  As little as a 10% 
decrease in adherence has been associated with a doubling of the HIV RNA level 
(Murphy et al., 2005).  Insufficient adherence oftentimes leads to very serious 
consequences such as increased HIV replication, the development of viral mutations, and 
resistance to the medication (Havlir, 2008; Reynolds, 2004).  Drug-resistant virus is a 
major concern and can be transmitted between individuals and from mother to child 
(Havlir, 2008).  Subsequently, treatment adherence in HIV (problems, correlates, and its 
 12 
assessment) has becomes a major thrust of the psychosocial research in HIV (Reynolds, 
2004). 
Treatment Adherence  
 Among youth with HIV, problems in adherence to HAART are well-documented 
and represent a major public health concern (Armstrong et al., 2003; La Greca & 
Bearman, 2003; Murphy et al., 2005; Radcliffe et al., 2006;  Simoni et al., 2007).  
Although generally considered to be suboptimal (Simoni et al., 2007) wide ranges of 
rates of adherence for children with HIV have been reported, with adherence as high as 
100% in some study samples and as low as 28% in others (Armstrong et al., 2003; 
Murphy et al., 2003; Naar-King, Frey, Harris, & Arfken, 2005; Simoni et al., 2007).   
Studies also suggest that rates are even lower as the complexity of treatment regimens 
increases (Murphy et al., 2005). 
 Although ranges of adherence estimates have been reported, precise estimates of 
adherence in children, adolescents, and adults with HIV are difficult to obtain due to 
deficiencies in the measurement of adherence (Berg & Arnsten, 2006; Reynolds, 2004; 
Simoni et al., 2007). Specifically, estimates of adherence rates vary widely according to 
the precise measurement used, and it is therefore impossible to provide an accurate 
summary of nonadherence in the population (Simoni et al., 2007).  In their review of 32 
studies regarding antiretroviral adherence among pediatric populations, Simoni and 
colleagues (2007) found a range of both direct and indirect methods of adherence 
measurement represented. Direct methods used included biological assays of an active 
drug and biological markers of drug ingestion.  Indirect methods used included self-
report, caregiver report, clinician assessment, medical chart review, clinic attendance, pill 
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count, pharmacy refill records, electronic drug monitoring (EDM), directly observed 
therapy (DOT), resistance testing and therapeutic impact such as VL, CD4 count, and 
disease staging, and mortality.  Interestingly, their study found that most studies 
incorporated caregiver and patient reports of adherence and very few used viral load, 
CD4 count and drug resistance as measures of adherence, despite the acceptance of these 
methods as being signs of nonadherence.  Other methods of adherence utilized in the HIV 
literature include daily logs and 24-hour recalls.    
 Individual methods of adherence measurements have different strengths and 
weaknesses with regards to reliability, validity and cost-effectiveness (Quittner, Modi, 
Lemanek, Ievers-Landis, & Rapoff, 2008).  For example, although self-report measures 
are inexpensive, available for multiple informants, and oftentimes comprehensive, they 
have been found to substantially overestimate actual rates of adherence and are generally 
difficult to use with young children (Naar-King et al., 2005; Quittner et al., 2008; Simoni 
et al., 2007).   Caregiver-report questionnaires tend to overestimate adherence when 
compared to self-report (Naar King et al., 2005; Simoni et al., 2007; Steele et al., 2001).  
Pill counts are often invalid as individuals do not consistently bring their pills with them 
to their appointments (Naar-King et al., 2005).  Electronic monitors (such as the MEMS 
bottle caps) represent a technologically advanced method of assessing adherence and 
provide continuous, real-time data.  However, these devices merely measure dispensing 
rather than ingestion of a given medication, are prone to malfunction, and are expensive  
(Quittner et al., 2008).  Attendance data, while useful in demonstrating clinic utilization, 
has been found to vary depending on the length of the interval assessed with longer 
intervals correlating with lower estimates (Simoni et al., 2007).  Estimates of adherence 
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also vary according to the methodology employed in studies (cut offs for optimal 
adherence, how assessed), as well as the types of medication regimens used (less 
tolerable regimens are linked to lower estimates) (Simoni et al., 2007).   
 Due to the variance in reliability of these measures, studies that incorporate 
multiple measures of adherence often provide more useful estimates (Simoni et al., 
2007).   For example, Naar-King and colleagues (2005) tested the utility and validity of 
different adherence measures for children perinatally infected with HIV (ages 2-17 years 
old) including caregiver-report, child 24-hour recall, physician report, and pill counts.  
Results highlighted some of the problems associated with the different methods of 
adherence measurement. Forty primary caregivers and 31 children, ages 8 and over, 
completed questionnaires.   Researchers assessed the validity of the different measures by 
comparing them with viral loads obtained as part of standard monthly clinic visits.   
Results indicated that the four adherence measures did not significantly correlate with 
one another.  Viral load was negatively correlated with caregiver reports, while child 
reports did not correlate with viral load.   Additionally, parent report was associated with 
lower concurrent viral load.   Pill counts were not found to be a valid form of assessment 
as 40% of families in the study did not bring in their pills for counting.   Researchers 
hypothesized that the poor reliability of child 24-hour recall interviews was due to 
reduced accuracy among younger participants (Naar-King et al., 2005).   
In conclusion, measuring treatment adherence in HIV represents a major 
challenge for researchers as no one “gold-standard” has been identified (Naar-King et al.,  
2005; Reynolds, 2004; Simoni et al., 2007).  A multi-method approach to adherence 
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measurement may be more useful than employing a single-measure of adherence 
(Quittner et al., 2008).  
 Psychosocial stressors. Increasingly, adherence is understood as a dynamic 
behavior, which changes over time and is influenced by a multitude of interrelated factors 
(Reynolds, 2004).  Suboptimal levels of adherence are likely due in part to the varied 
psychosocial and practical barriers facing youth with HIV.  As HIV has become viewed 
as a chronic illness (CI), researchers are focusing on elucidating the stressors facing 
people with HIV both as they relate to psychosocial adaptation and health outcomes 
(Armstrong et al., 2003; Bachanas et al., 2001; Lewis, 2001).   
In addition to the typical challenges of growth and development such as identity 
formation, decisions about sexual and romantic relationships, drug use, etc., youth with 
CI’s are faced with varied illness-related stressors (Boekaerts & Roder, 1999; Hample et 
al., 2005; Reisner, Mimiaga, Skeer, et al., 2009).   Challenges present across many CI’s 
include: restrictive treatment regimens, frequent hospitalizations, painful medical 
procedures, social rejection, changes in appearance, declining physical health, frequent 
school absence, and isolation from peer group (Hample et al., 2005; Lewis et al., 1994).  
Others include: receiving the diagnosis, building relationships with healthcare providers, 
and confronting the possibility of death (Brown, Lourie, & Pao, 2000; Spirito, Stark, & 
Knapp, 1991). 
In addition to the aforementioned stressors, however, youth and families with 
HIV are confronted with a number of disease specific stressors conceptualized as 
impeding optimal treatment adherence such as: the difficulty of following a very 
complicated treatment regimen, child behavior problems, refusal, poor taste, food 
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interactions, and difficulty with pill swallowing (Armstrong et al., 2003).  Perinatally-
infected children and adolescents with HIV are also thought to be at increased risk for 
adjustment difficulties due to the effects of the disease on brain structures involved in the 
regulation of behavior, emotion, and cognition (Bachanas et al., 2001; Havens, Whitaker, 
Feldman, & Ehrhardt, 1994).  Additionally, many adolescents with HIV are responsible 
for their own treatment and do not have the familial or parental support they might need 
to maintain good adherence (Armstrong et al., 2003).   
Another unique stressor affecting children and adolescents both behaviorally and 
perinatally infected with HIV, is the stigma associated with having the disease (Brown, 
Lourie, & Pao, 2000; Mellins, Brackis-Cott, Dolezal, & Abramas, 2006).  Despite 
widespread education and outreach regarding the epidemic, HIV infection continues to be 
strongly associated with shame for children and their families. The stigma and shame 
associated with having HIV infection impacts the family and other interrelated systems 
such as school, community, and other relationships (Brown, Lourie, & Pao, 2000).  
Concerns about stigma give rise to a burden of secrecy around the diagnosis and 
treatment among children and adolescents with HIV and their families, which can lead to 
social isolation or ostracism (Brown, Lourie, & Pao, 2000; Miller, 2001; Simoni et al., 
2007).   Furthermore, many individuals fear risking disclosure of their status through 
possession of medications and/or filling prescriptions, and subsequently do not adhere to 
their prescribed regimens (Armstrong et al., 2003; Rao, Kekwaletswe, Hosek, Martinez, 
& Rodriguez, 2007).   
The issue of deciding to inform perinatally-infected children of their HIV status 
therefore presents parents and caregivers with fear of distressing their child (Brown, 
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Lourie, & Pao, 2000; Lipson, 1994).  Furthermore, mothers of children who are HIV 
positive, are often concerned about the impact of disclosing their own status to their 
children (Armistead, Tannenbaum, Forehand, Morse, & Morse, 2001).  Armistead and 
colleagues (2001) used interviews to explore disclosure among 87 HIV-infected African 
American mothers. They found that less than one-third of mothers disclosed their own 
HIV status to their children.   Lack of disclosure may also lead to problems with 
medication adherence as it contributes to shame about the disease and does not allow for 
modeling of adherence behaviors to occur (Brown, Lourie, & Pao, 2000).   
In addition to the burdens of stigma and issues of disclosure, perinatally and 
behaviorally-infected individuals with HIV often experience a number of other negative 
life events and stressors associated with HIV infection.  Children and adolescents with 
HIV have often lost their parents, family members, and friends to the disease (Mellins et 
al., 2006; Roth, Siegel, & Black, 1994), and these multiple losses and issues of grief 
represent other stressful events related to HIV infection (Brown, Lourie, & Pao, 2000). 
Children and adolescents infected with HIV are confronted with other challenges related 
to environmental risk factors.  As noted previously, HIV disproportionately affects ethnic 
minority populations, predominantly African American and Hispanic individuals, and 
families living in poverty (Armstrong et al., 2003; Brown, Lourie, & Pao, 2000).  
Therefore, children and adolescents with HIV and their caregivers are confronted with 
challenges associated with having a lower socioeconomic status such as limited access to 
health care, chronic poverty, limited resources, substance abuse, and stressors of inner-
city life (Armstrong et al., 2003; Brown, Lourie, & Pao, 2000; Mellins et al., 2006; 
Simoni et al., 2007).  
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Studies of adolescents behaviorally-infected with HIV have indicated the 
potential importance of negative life events and sociodemographic variables in 
contributing to problems with adjustment.   The first large-scale study to assess the 
psychosocial functioning of adolescents and young adults behaviorally infected with HIV 
was the Reaching for Excellence in Adolescent Care and Health (REACH) project 
(Murphy et al., 2000).   This study included 230 adolescents between the ages of 12 and 
19 who became infected with HIV through sexual behavior or injection drug use.  Using 
hypotheses based on adult research, investigators assessed the relationship between life 
events, social support, coping, depression, and anxiety through self-report measures.   
Results indicated that life events with high impact (such as being prescribed HIV 
medications or family financial problems) were associated with higher levels of 
depression as measured by the Center for Epidemiologic Studies Depression Scale (CES-
D; Radloff, 1977) and anxiety as measured by the Manifest Anxiety Scale (Reynolds & 
Richmond, 1978).  Contrary to the hypothesis of the study, neither social support nor 
adaptive coping skills (as measured by a coping scale created by the authors) served as 
buffers of the effects of stressful events.  Of note, several stressful life events including 
family financial problems, parental abuse of alcohol, parental arguing and fighting, 
changing schools, serious accidents, and death in the family were each reported by about 
25% of the total sample.  
Additionally, HIV/AIDS frequently affects families with multi-generational 
histories of victimization and trauma (Havens, Mellins, & Pilowski, 1996; Martinez, 
Hosek, & Carleton, 2009; Radcliffe et al., 2006).  Thus, children and adolescents with 
HIV may also experience a high incidence of traumatic life events.  
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PTSD in youth with HIV.  The varied and complex stressors facing this population 
coupled with the high rates of traumatic life experiences suggest that the prevalence of 
post-traumatic stress may be an important variable to explore in pediatric HIV.  Very 
little is currently known about the prevalence of posttraumatic stress symptomatology 
among children and adolescents with HIV and its potential link to poor health outcomes.  
PTSD is characterized in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR; American Psychiatric Association, 2000) as having been 
exposed to an extreme traumatic stressor in which there is actual or threatened death or 
serious injury, or other threat to one’s physical integrity.  The experience of a traumatic 
stressor must include reactions of extreme fear, helplessness, or horror.  Symptoms are 
clustered around three criteria: re-experiencing the event, avoidance of reminders of the 
event and hyper-arousal.  Unlike non-pathological post-traumatic stress responses, 
symptoms of PTSD must be present for at least one month following the traumatic event, 
and must cause functional impairment.  
 Interestingly, PTSD has only been thought to occur in children and adolescents 
for about the past two decades (Meiser-Stedman, 2002).  Despite burgeoning research in 
this area, relatively little is currently known about the range of traumatic experiences and 
rates of PTSD among children and adolescents in community samples, as most research 
has focused on groups experiencing specific traumas such as sexual abuse, crime, and 
natural disasters (Giaconia et al., 1995).  
 However, existing research suggests that urban children and adolescents may be 
at risk for PTSD because they experience especially high rates of traumatic events, in 
particular community violence (Martinez, et al., 2009; Schwab-Stone et al., 1995).  In 
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one study, researchers surveyed 2248 adolescents (from 6th through 10th grade) in an 
urban public school and found that more than 40% of those surveyed reported exposure 
to a stabbing or shooting in the past year.  Seventy-four percent of those surveyed 
reported feeling unsafe (Schwab-Stone et al., 1995).   Additional studies have indicated 
that inner-city youth experience high levels of community violence (Martinez et al., 
2009).  Cooley-Quille and colleagues (2001) investigated exposure to community 
violence in 185 inner-city high school students (mean age =15 years). Based on scores 
obtained on the Children’s Report of Exposure to Violence (CREV; Cooley, Turner, & 
Beidel, 1995), 48% of the sample was exposed to high levels of community violence.  
 Results from the recently published National Survey of Adolescents provide 
support for the link between exposure to interpersonal violence and a risk for PTSD 
(Kilpatrick et al., 2003).   A sample of 4,023 adolescents (ages 12-17) were surveyed 
through a highly structured telephone interview which assessed information across 
domains of trauma history, demographic and family variables, and PTSD, Major 
Depressive Episode (MDE), and substance abuse/dependence (SA/D).  Results indicated 
that the prevalence of PTSD, MDE, and SA/D was relatively high with 15.5% of boys 
and 19.3% of girls experiencing at least one of the diagnoses within the past year.  
Experiences of interpersonal violence (such as sexual and physical assault and witnessed 
violence) increased the risk of these disorders even when controlling for demographic 
variables and familial substance abuse problems (Kilpatrick et al., 2003).   Lipschitz and 
colleagues (2000) investigated correlates of PTSD in 90 female adolescents (ages 12 to 
21) presenting at an adolescent primary care clinic.  Ninety-two percent of the sample 
endorsed experiencing at least one trauma.  The most common traumatic events endorsed 
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by the sample were witnessing community violence and hearing about a homicide.  
Twelve girls met criteria for full PTSD (Lipschitz, Rasmusson, Anyan, Cromwell, & 
Southwick, 2000). 
 Studies have suggested that ethnic minority adolescents may experience more 
traumatic events than their white counterparts (Cuffe et al., 1998).   Since HIV 
overwhelmingly affects urban youths of ethnic minority status it is likely that a high 
percentage of children and adolescents with HIV will have experienced traumatic life 
events.   While these traumatic events may increase their risk for HIV infection in the 
first place (Martinez et al., 2009), they may also simply overlap with the diagnosis of 
HIV itself.  Children and adolescents with HIV may therefore be at increased risk for 
mental heath difficulties such as post-traumatic stress symptoms (PTSS) or PTSD.   In 
addition to exposure to traumatic events such as interpersonal violence, youth with 
children and adolescents may be at increased for PTSS or PTSD due to the traumatic 
nature of the diagnosis of the disease itself as well as the associated treatment and 
disease-related stressors. Despite these facts, however, there is a paucity of research on 
the presence of PTSS/PTSD in children and adolescents with HIV.   
  A recent study by Radcliffe and colleagues (2006) represents the first study to 
examine trauma history and post-traumatic stress in a sample of 30 older adolescents and 
young adults (ages 18-24 years) behaviorally infected with HIV.  Noting the threat to 
body integrity and life inherent in an HIV diagnosis and its treatment as well as 
avoidance symptoms often relating to poor adherence to medical care and fears regarding 
disclosure, Radcliffe and colleagues sought to explore post-traumatic stress in the 
population as it relates to both HIV and other traumatic life events. In order to investigate 
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the participants’ exposure to trauma, the Traumatic Events Screening Inventory (TESI; 
Ford & Rogers, 1997; Ribbe, 1996) semi-structured interview was used.  An item 
regarding receiving an HIV diagnosis was added.  The Posttraumatic Stress disorder 
Checklist-Civilian Version (PCL-C; Dudley et al, 1995) was then administered twice, 
once referencing the HIV experience, and once referencing another difficult event.  
Interestingly, 93% of the participants reported that receiving an HIV diagnosis was 
traumatic.  Of those, 13.3% met criteria for PTSD in response to receiving an HIV 
diagnosis, while an additional 17% showed posttraumatic stress symptoms.  A variety of 
additional types of traumatic events were reported by the sample including: neighborhood 
violence, being in or seeing an accident, family violence, having a family member 
incarcerated, being physically attacked and sexual abuse.  Fifty percent of the participants 
reported symptoms of posttraumatic stress in response to these “other” traumatic events. 
More recently, Martinez and colleagues (2009) explored the prevalence of 
violence and mental health disorders in a clinic sample of 174 HIV-positive youth (ages 
14 to 24) who were consecutively enrolled in the clinic over 8 years.  Using both a semi-
structured diagnostic interview and the Client Diagnostic Questionnaire (CDQ; Aidala, 
Havens, Peake, & Keane, 2002; Spitzer et al., 1994), researchers found that a significant 
portion of their sample had experienced exposure to violent events in some form.  
Specifically, a quarter of the sample had experienced physical assault and/or abuse during 
childhood, 19% experienced assault and/or abuse during adolescence, 28% experienced 
sexual assault/sexual abuse during childhood, 15% experienced it during adolescence, 
and almost half of participants (44%) endorsed witnessing violence in their families.  
Moreover, 28% of their sample met criteria for PTSD, with significant associations found 
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between the exposure to violent events and PTSD.  The authors of this study highlighted 
the potential link between abuse and the risk taking behavior that may lead to the 
contraction of HIV, as well as the association between mental health difficulties and 
treatment adherence.  
Much research remains to be done towards understanding posttraumatic stress 
among children and adolescents behaviorally and perinatally-infected with HIV, 
particularly as it may relate to the diagnosis of HIV.  Existing research points to the high 
incidence of traumatic life events experienced by this population and the importance of 
investigating their impact on health outcomes.  Research regarding posttraumatic stress in 
other chronic illness populations as well as in adults with HIV supports further 
investigation into this area.  
PTSD in chronic illness.  Since the 1994 revision of the DSM, the diagnosis or 
treatment of a life-threatening illness has been considered a precipitating event for PTSD 
(Katz & Nevid, 2005; Kazak et al., 2004; Stuber & Shemesh, 2006).  This addition to the 
PTSD diagnostic criteria was made in response to field trials such as those by Pelcovitz 
and colleagues (1996) and Alter and colleagues (1996), which documented the presence 
of PTSD symptoms in children actively undergoing bone marrow transplants, as well as 
survivors of pediatric cancer and their mothers.  To date, most of the post-traumatic stress 
reactions in medical populations have been conducted with adults, although a growing 
base of research on post-traumatic stress in pediatric medically ill populations exists 
(Stuber & Shemesh, 2006).  For example, research has found PTSD symptoms in adult 
survivors of myocardial infection (Kutz, Shabtai, Solomon, Neumann, & David, 1994; 
Shemesh et al., 2001; Shemesh et al., 2004) and women with breast cancer (Green et al., 
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1998; Smith, Redd, Peyser, & Vogl, 1999).  Most of the research on PTSD in pediatric 
populations has involved children with cancer, and survivors of childhood cancer, and 
conceptualized cancer and its treatment as potentially traumatic events (Barakat et al., 
1997; Hobbie et al., 2000; Kazak et al., 2004; Stuber et al., 1997; Stuber & Shemesh, 
2006).  Research on survivors of childhood cancer has yielded important findings. Some 
studies have indicated that while survivors of childhood cancer do not display higher 
rates of PTSD than controls, they do display high rates of posttraumatic stress symptoms 
(PTSS) particularly in the clusters of reexpereincing and arousal (Kazak et al., 2004; 
Kazak et al., 1997).  Also, young adult survivors tend to present with higher raters of 
PTSD and PTSS than younger survivors (Kazak et al., 2004). 
 For example, Barakat and colleagues (1997) compared posttraumatic stress 
symptoms in 309 survivors of childhood cancer between 8 and 20 years of age and their 
parents with 219 healthy children and their parents.   They found that although the 
survivors themselves reported experiencing clinically significant levels of posttraumatic 
stress symptoms related to the cancer and its treatment, they did not meet the diagnostic 
criteria for PTSD (Barakat et al., 1997; Stuber et al., 1997).  The authors concluded that 
the diagnosis of cancer itself, as well as the treatment for childhood cancer likely 
contributed to the development of posttraumatic stress symptoms. Parents of cancer 
survivors were also found to experience symptoms of posttraumatic stress significantly 
more than parents of children without a medical history (Barakat et al., 1997).  In 
contrast, this study was followed by an investigation of 78 young adult survivors of 
cancer (ages 18 to 40 years).  In this sample, 20.5% met DSM-IV criteria for PTSD 
including clinically significant levels of intrusive and avoidance symptoms.  Those 
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individuals with PTSD were found to have had a higher perceived current life threat, 
more intense treatment, and higher levels of distress than those participants who did not 
have PTSD (Hobbie et al., 2000; Rourke, Stuber, Hobbie, & Kazak, 1999).   
Pediatric Medical Traumatic Stress.  In response to findings regarding children 
exposed to the trauma of medical illness, and efforts to better understand the experience 
of children and families in medical settings, Kazak and colleagues (2006) presented a 
model of Pediatric Medical Traumatic Stress (PMTS).  The PMTS model addresses the 
traumatic stress responses of children and their families to potentially traumatic medical 
events (PTE’s) such as arousal, reexperiencing and avoidance.  The authors assert that 
these symptoms may disrupt functioning even if they do not reach a level meeting criteria 
for a diagnosis of PTSD.  The model describes three general phases as contributing to the 
eventual long-term response of PMTS:  During the first phase, or peritrauma, the 
potentially traumatic event (PTE) and its immediate aftermath occur.   During this phase, 
several factors are theorized as contributing to the subjective experience of trauma 
including pre-existing factors (coping skills, family support, psychopathology), and 
characteristics of the event itself (life threat and/or the likelihood of the event evoking 
helplessness, fear, and horror).  The second phase encompasses the early acute, ongoing, 
and evolving secondary responses to trauma.  During this phase, the reactions of patients 
and their families to the challenges and demands related to the medical condition may 
persist over time and subsequently impact behavioral functioning such as treatment 
adherence.  Reactions during this phase are therefore linked to health outcomes.  Phase 
III include the longer-term traumatic stress responses which persist when the immediate 
threat or physical components of the illness have resolved.  The authors note that studies 
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of pediatric traumatic responses have revealed problems in functioning related to PTSS 
many years after the onset of illness and ending of treatment.  The PMTS model 
represents an empirically supported framework for evaluating posttraumatic stress in 
pediatric patients and their families.  
In summary, research with survivors of childhood cancer and their families 
highlights the potentially traumatic nature of pediatric chronic illness.  Like cancer, HIV 
carries with it a threat to bodily integrity and the potential for death.  Research with 
survivors of cancer and other chronic illnesses underscores the importance of considering 
the potentially traumatic nature of the disease itself and stresses that individuals may be 
impacted by posttraumatic stress symptoms even if they do not meet full criteria for 
PTSD (Kazak et al., 2006).  
PTSD in adults with HIV.  Adults infected with HIV have been found to present 
with high rates of PTSD (Boarts, Sledjeski, Bogart, & Delahanty, 2006; Brief et al., 
2004).  While PTSS/PTSD and HIV may be associated through a third variable such as 
exposure to traumatic events, it is also possible that HIV and PTSD are causally 
connected as in the case of cancer and other chronic illnesses.  However, most of the 
studies which have assessed PTSD in adults living with HIV have largely conceptualized 
PTSD as resulting from a history of traumatic events as opposed to the impact of or 
trauma surrounding the disease and its diagnosis (Allers & Benjack, 1991; Boarts et al., 
2006; Brief et al., 2004; Kimmerling, Armistead, & Forehand, 1999).  Overall, this 
research suggests that high rates of PTSD have been found among adults with HIV, and 
that individuals with HIV are more likely to have had a history of trauma than the general 
population or even their uninfected demographically matched counterparts (Boarts et al., 
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2006; Brief et al., 2004; Katz & Nevid, 2005; Kimmerling, Calhoun, et al., 1999).   For 
example, in one study, Safren, Gershuny, & Hendriksen (2003) found that more than half 
of a sample of 75 adults with HIV met diagnostic criteria for PTSD. 
Researchers have hypothesized that high rates of childhood abuse, sexual 
victimization and other traumatic experiences may be linked to HIV in that physical and 
sexual abuse has been associated with engagement in subsequent high risk behavior such 
as unprotected sexual activity, sex with multiple partners, and drug use (Brief et al., 2004; 
Martinez et al., 2009; Reisner, Mimiaga, Safren, & Mayer, 2009).   For example, 
Kimmerling, Armistead, and Forehand (1999) investigated the prevalence of 
victimization experiences (rape, physical assault, robbery/attack) among 81 African 
American women with HIV and a demographically matched non-infected control group.  
Women’s ratings on the Life Stressor Checklist (LSC: Wolfe & Kimmerling, 1997) 
revealed that most (62.1%) of the women with HIV had been exposed to at least one 
potentially traumatic event in their lives.  Furthermore, women who reported 
experiencing traumatic experiences had almost three times the risk for HIV infection than 
women who did not report being exposed to traumatic events. Although women reported 
exposure to a number of potentially traumatic events, physical and sexual assault in 
particular (such as robberies/muggings, and rape) contributed to the greatest amount of 
variance towards HIV infection (Kimmerling, Armistead et al., 1999).   Other studies 
have pointed to a pattern of repeated traumatization among women with HIV (Allers & 
Benjack, 1991; Brief et al., 2004).  Similarly high rates of sexual trauma histories have 
been noted among men with HIV (Brief et al., 2004; Holmes, 1997).   
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Few studies with HIV-infected adults have evaluated PTSD related to the 
experience of having HIV.   Kelly and colleagues (1998) used the Diagnostic Interview 
Schedule (DIS: Robins, Helzer, Croughan, & Ratcliff, 1981) to assess the prevalence of 
PTSD in 61 homosexual/bisexual men with HIV in response to HIV infection, and found 
that 30% met criteria for PTSD (Kelly et al., 1998).   In another study, Katz and Nevid 
(2005) examined risk factors contributing to PTSD symptomatology in 102 women with 
HIV.   For this study, authors modified the PTSD Checklist Civilian Version (PCL-C) 
(Chemtob & Herriott, 1994) to ask specifically about the experience of “being diagnosed 
and treated for HIV”,  and found that the degree of HIV-related PTSD symptoms was 
associated with a greater number of HIV-related physical symptoms (Katz & Nevid, 
2005).  Of importance to the present study, authors noted the need for studies 
investigating the contributions of PTSD in individuals with HIV towards problems with 
medication adherence (Katz & Nevid, 2005).   
 In summary, high rates of PTSD and PTSS have been noted among adults with 
HIV.  While largely conceptualizing PTSD as related to the high incidence of traumatic 
life experiences noted in this population, only a few studies acknowledge the potentially 
traumatic nature of the HIV diagnosis and its related treatment.  
 PTSD and adherence.  PTSD and posttraumatic stress symptoms in individuals 
with HIV may contribute to severe health-related consequences.  The symptoms of 
posttraumatic stress may impact an individual’s ability to adhere to his/her treatment 
regimen and prescribed health behaviors.  For example, it is possible that an individual 
with reexperiencing symptoms related to the diagnosis of HIV might feel marked distress 
while attending clinic appointments (the site of his/her diagnosis) and may therefore 
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show poor clinic appointment attendance.  Similarly, avoidance symptoms may cause an 
individual to avoid following through with care, as well as disclosure of his/her status to 
significant others (Radcliffe et al., 2007).  This may leave individuals without a  support 
system in place and may make it harder to adhere to complex treatment regimes.  The 
medication itself may serve as a painful reminder of the disease for some (Roberts & 
Mann, 2000).   Hyperarousal symptoms may also interfere with needed social support by 
impeding relationships with family, friends, and health care providers (Radcliffe et al., 
2007).   As previously discussed, PTSS related to traumatic life events may also affect 
treatment adherence in that they may lead to increased risk-taking behaviors and 
subsequently a general pattern of poor self-care (Brief et al., 2004; Reisner, Mimiaga, 
Skeer, et al., 2009).  Individuals who have experienced interpersonal traumas such as 
sexual abuse, for example, may also have difficulty trusting others, which in turn may 
compromise their relationship with medical providers and lead to poor treatment 
adherence (Altice, Mostashari, & Friedland, 2001; Meade, Hansen, Krochman, & 
Sikkema, 2009).  
  The presence of PTSD symptomatology in adults with HIV has been strongly 
negatively associated with disease course including decreased CD4 cell counts, increased 
viral loads and other physical health problems (Boarts et al., 2006; Brief et al., 2004; 
Cohen et al., 2001; Kimmerling, Armistead et al., 1999; Reilly, Clark, Schmidt, Benight, 
& Kissinger, 2009).  Importantly, it is often noted that symptoms of posttraumatic stress 
(without a diagnosis of PTSD) still impact treatment adherence (Meade et al., 2009).  
Others have noted a strong relationship between the number of traumatic life events and 
nonadherence. (Leserman, Ironson, O’Cleirigh, Fordiani, & Balbin, 2008; Mugavero et 
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al., 2006).  For example, Kimmerling, Armistead, and Forehand (1999) found that HIV 
positive women who had a history of three or more traumatic experiences had a higher 
number of AIDS related complications than women with fewer experiences of trauma or 
victimization.   In a multi-site study, Mugavero and colleagues (2006) investigated 
lifetime traumatic events in a cohort of 474 adults with HIV.  Self-report adherence data 
was collected and antiretroviral nonadherence was found to be significantly associated 
with lifetime traumatic events, particularly for individuals who had experienced multiple 
traumatic events.  PTSD may therefore impact disease course through its associated 
behavioral changes or outcomes resulting in poor medication and overall treatment 
adherence (Boarts et al., 2006; Brief et al., 2004; Cohen, et al., 2001; Delahanty et al., 
2004; Reisner, Mimiaga, Safren et al., 2009a).  
Other researchers have assessed the presence of PTSD/PTSS and comorbid 
symptomatology in adults with HIV (Boarts et al., 2006).  For example, Boarts and 
colleagues (2006) investigated the independent and comorbid influence of PTSD and 
depression symptoms on adherence in 57 adults living with HIV.  Researchers measured 
symptoms of depression using the CES-D (Radloff, 1977) and PTSD symptoms using the 
Post-traumatic Diagnostic Scale (PDS; Foa et al., 1997).  Researchers measured 
adherence to medication via a self-report interview, obtained CD4 cell counts, and viral 
loads, from medical records.  Data were obtained at two time points, approximately 3 
months apart.   Results revealed that 19% of participants reported receiving the HIV 
diagnosis as their most distressing trauma, while 28% reported other traumas as being the 
most distressing, and 11% reported more than one trauma as being the most distressing.  
According to scores obtained on the PDS, 42% of participants would have likely met full 
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diagnostic criteria for PTSD.  Results indicated that both PTSD and symptoms of 
depression predicted lower subsequent medication adherence.  Those participants with 
comorbid PTSD and depression were less likely to adhere to HAART and more likely to 
have a detectable viral load.  More recently, Vranceanu and colleagues (2008) 
investigated the degree to which positive screens for PTSD and depression were unique 
predictors of medication adherence in a sample of 156 HIV-infected adults.  A high co-
occurrence of both disorders was found (65% percent of the individuals who screened 
positive for PTSD (21% of the sample) also screened positive for depression).  PTSD and 
depression were significantly inversely related to adherence; however, PTSD was not a 
significant predictor of adherence alone, whereas depression was.   PTSD did increase the 
likelihood of depression, however, and therefore was shown to have an indirect effect on 
treatment adherence.  Several issues limited the findings of this study including the fact 
that the assessment of PTSD was likely inadequate as the authors used a very limited 4-
item positive screen for PTSD, while they used a 37 item screen for depression.   Several 
participants were also treated with antidepressants, the use of which may have impacted 
PTSD severity as well.   In conclusion, while some findings stress the importance of the 
consideration of other areas of psychological distress in addition to PTSD/PTSS, there is 
a substantial literature base supporting the link between traumatic life events, 
posttraumatic stress and treatment adherence.  
 Conversely, almost no studies have investigated the impact of PTDS/PTSS on 
youth with HIV.  Recently, Radcliffe and colleagues (2006) presented findings on 
adherence from the aforementioned study involving adolescents and young adults 
behaviorally infected with HIV.  Results suggested that adherence as measured by 
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provider ratings was in fact significantly related to the occurrence PTSD (Radcliffe et al., 
2006).  Moreover, adherence was significantly related to PTSD only with non-HIV 
trauma.   More research is clearly needed to elucidate the role of PTSD/PTSS in HIV 
treatment adherence for behaviorally and perinatally-infected youth.  
Other factors associated with adherence.  Beyond posttraumatic stress, 
Researchers have begun to attempt to uncover other determinants of nonadherence in 
HIV (Chesney, 2000).  Adult HIV research has elucidated 4 main categories of critical 
factors consistently linked to adherence: patient factors, medication regimen complexity 
and requirements (pill burden, dosing schedules, side effects), the patient-provider 
relationship, and the system of care (Chesney, 2000; Reynolds, 2004; Ricart et al., 2002).  
Patient factors include: psychological distress (Brief et al., 2004; Hermann et al., 2008; 
Reynolds, 2004; Uldall et al., 2004), depression (Brief et al., 2004; Herman et al., 2008.; 
Protopopescu et al., 2009; Reynolds, 2004; Uldall et al., 2004), posttraumatic stress 
(Boarts et al., 2006; Brief et al., 2004; Cohen, et al., 2001; Kimmerling, Armistead, et al., 
1999; Reilly et al., 2009) (psychoactive drug use/substance abuse  (Herman et al., 2008; 
Protopopescu et al., 2009; Reynolds, 2004)  cognitive dysfunction (Reynolds, 2004), lack 
of social support (Protopopescu et al., 2009; Reynolds, 2004), financial obstacles, lack of 
education, and health beliefs (Aversa & Kimberlin, 1996; Chesney, 2000; Molassiotis et 
al., 2002; Muma, Ross, Parcel, & Pollard, 1995).  
Less is known about factors associated with adherence among HIV-infected 
children, adolescents and young adults (Murphy et al., 2005; Steele & Grauer, 2003) but 
broad areas of factors that have been found to relate to adherence in youth with HIV 
include: demographic factors, psychosocial factors, disease factors, treatment regimen 
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factors, and practitioner factors (Reisner, Mimiaga, Skeer, et al., 2009).   In addition to 
the research noted previously regarding the relationship between depression and 
adherence, other psychosocial factors found to be associated with treatment adherence 
include psychological distress (Naar-King et al., 2006), and health beliefs  (Belzer, 
Fuchs, Luftman, & Tucker, 1999; Reddington et al., 2000).  In one study, Belzer and 
colleagues (1999) assessed adherence in a sample of 31 behaviorally-infected adolescents 
and young adults, many of whom were identified as having histories of substance abuse 
and homelessness.   A self-report adherence questionnaire was administered, and results 
indicated that good adherence (i.e. 90%) was associated with strong endorsement of the 
belief that HIV medications would improve their quality of life (Belzer et al., 1999).   
Reddington and colleagues (2000) assessed the relationship between parental 
health beliefs and parent-reported adherence in a sample of 90 children (median age = 7.9 
years), and found that parents of adherent children endorsed high medication efficacy.  
Conversely, Steele and colleagues (2001) did not find a relationship between parental 
health beliefs and adherence in a smaller sample of 30 children, but cited low power as 
possible explanation of the lack of finding. 
In their review of 50 studies investigating medication adherence in pediatric HIV, 
Simoni and colleagues (2007) note that a major limitation of much of the research 
investigating correlates of adherence in pediatric HIV is that studies derive data from 
clinical experiences and surveys rather than from theoretical models. Conclusions from 
the current literature regarding correlates of adherence in pediatric HIV are also limited 
due to few existing studies (Steele & Grauer, 2003).  However, some conclusions may be 
drawn.  Specifically, the existing literature has identified potential predictors of 
 34 
adherence, including depressive symptoms (Murphy et al., 2005) and health beliefs 
(Reddington et al., 2000).   
Health belief model and adherence.  The Health Belief Model (HBM; 
Rosenstock, 1966) has been frequently utilized as an organizational framework for 
explaining and predicting adherence to health care recommendations (Harrison, Mullen, 
& Green, 1992).  It is based on the assumption that a person’s behavior is determined by 
his or her perception of the world and can be explained by four main dimensions:  
perceived susceptibility to a specific disease, perceived seriousness or severity of the 
disease, perceived threat of the disease, and the perceived benefits of taking preventative 
action minus the perceived barriers to taking such action (Rosenstock, 1966).  In a meta-
analysis of 51 studies using the HBM with adults, Harrison and colleagues (1992) found 
that although only 16 studies in the analyses included all four HBM dimensions, 
significant positive relationships were found between perceptions of severity, perceived 
susceptibility, benefits and barriers and adherence to medication regimens in the expected 
directions.   
Within adult HIV research, several studies have highlighted the relationship 
between patients’ views about their illness and beliefs about the effectiveness of their 
medication with treatment adherence (Molassiotis et al., 2002).  Muma and colleagues 
(1995) evoked the HBM to investigate the relationships among health beliefs, attitudes, 
and Zidovudine adherence in 52 adults with HIV.  In order to assess health beliefs, the 
authors generated a survey which reflected the participants’ perceived susceptibility to 
and perceived severity of HIV.  A factor analysis of the items, which was correlated with 
laboratory makers of adherence, indicated that skepticism about the effectiveness of 
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treatment emerged as a significant independent predictor of adherence. The authors 
suggested that this finding is consistent with the HBM, which holds that the difference 
between one’s perceived benefits of action and perceived barriers to action contribute to 
outcome (Muma et al., 1995).  
The Adult AIDS Clinical Trials Group’s (AACTG) large-scale study investigating 
the impact of adherence on clinic health outcome in 75 adult patients with HIV also 
investigated the relationship between health beliefs and adherence (Chesney et al., 2000).  
Using the AACTG Adherence Instruments and an adherence self-efficacy and beliefs 
about medication scale (also designed for their study) researchers found that less adherent 
patients reported lower adherence self-efficacy in that they were less sure that not taking 
their medicine would contribute to negative health outcomes, and they were less 
confident about their ability to take the medication as directed.   
Closely related to the dimensions of the HBM is the health locus of control (HLC) 
construct, which describes the extent to which an individual believes that his/her health is 
determined by his/her behavior.  The original Health Locus of Control Scale (Wallston, 
Wallston, Kaplan, & Maides, 1976) reflected two dimensions of HLC.  The first 
dimension contains “health externals” who believe that the factors which determine their 
health are outside of their control and are primarily due to luck, fate, chance, or powerful 
others (Wallston et al., 1976).  Along the other dimension are “heath-internals” who 
believe that the locus of control for health is internal, and that their health is determined 
by their behavior.  The updated Multidimensional Health Locus of Control Scale 
(MHLC; Wallston, Wallston, & DeVellis, 1978) assesses whether an individual believes 
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that his/her health is due to an internal health locus of control, a Powerful Others health 
locus of control, or a Chance health locus of control.   
 Several authors have encouraged the use of the health locus of control theory in 
conjunction with the HBM as it is a form of a health belief  (Nagy & Wolfe, 1984; 
Wallston & Wallston, 1978).  Aversa and colleagues (1996) examined the relationships 
between perceived severity, perceived susceptibility, benefits/barriers, cues to action, and 
health locus of control to medication adherence in a sample of 99 adults with HIV.  
Health locus of control was measured by the Multidimensional Health Locus of Control 
Scale (MHLC; Wallston, Wallston, & DeVellis, 1978), and health beliefs were measured 
via questions that asked about what would happen if the participant were to discontinue 
treatment (perceived susceptibility), how serious they perceived their disease to be 
(perceived severity) and perception of benefits versus barriers of treatment.   Adherence 
was measured via a 15-minute telephone interview. Results suggested that individuals 
who perceived greater barriers and less confidence in the ability of the medication to 
protect them from AIDS-related illness were more likely to discontinue with treatment.  
Participants who indicated good treatment adherence were the most optimistic about the 
benefits and effects of antiretrovirals.  Those individuals with inconsistencies in 
adherence had a significantly greater internal health locus of control orientation than 
individuals who discontinued treatment.   
Molassiotis and colleagues (2002) also provided support for the utility of the 
HBM and HLC constructs in predicting treatment adherence.  The AACTG self-report 
measure of adherence (Chesney et al., 2000), MHLC and AACTG Correlates of 
Adherence questionnaire (Chesney et al., 2000) were used to examine  predictors of 
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adherence for 136 adults with HIV in Hong Kong.  T-test analyses indicated that 
individuals who believed that not taking their medications would lead to problems with 
resistance were more adherent to their medication. Furthermore, participants who 
endorsed an internal health locus of control were also more adherent to their medication 
regimen.   
Taken together, these studies suggest that the HBM and the HLC construct are 
useful in helping to determine factors relating to adherence in adults with HIV.  
Specifically, although cross-sectional in design, research indicates that individuals who 
adhere to treatment for HIV tend to believe that taking their medication will have an 
effect on their health and that their health status is in a large part a result of their actions.  
Health locus of control not been extensively explored in pediatric HIV studies, however, 
as the literature examining correlates of adherence in children and adolescents with HIV 
is scarce.  Furthermore, the pediatric HIV adherence literature fails to conform to a 
specific model or framework of adherence, such as the Health Belief Model, making it 
difficult to link findings across different studies (Steele & Grauer, 2003).  Further 
investigations into the correlates of adherence in this population will help identify targets 
for clinical interventions aimed at improving adherence.  
Purpose of the Present Study 
Progress in both the attention paid to the HIV epidemic, as well as advances in 
medical care and survival rates, have caused HIV to be viewed as a chronic illness to 
which children and adolescents must learn to adapt (Armstrong et al., 2003; Bachanas et 
al., 2001; Lewis, 2001).   In addition to the typical challenges of growth and 
development, adolescents with HIV are confronted with varied illness-related and non-
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illness-related stressors such as: complicated medication regimens, issues of grief and 
loss, changes in caregivers, responsibility for their medical care, and stressors related to 
urban-living and lower socioeconomic status (Brown, Lourie, & Pao, 2000).   Challenges 
associated with HIV and other life stressors put children and adolescents at risk for 
problems in adaptation such as posttraumatic stress.  
Kazak and colleagues (2006) have presented a model of Pediatric Medical 
Traumatic Stress (PMTS) to provide an empirically-based framework with which to 
better understand the experience and response of medically-involved children and 
families to potentially traumatic medical events.   Created in response to findings which 
indicated high rates of PTSS among young adult survivors of cancer, the model has 
helped to describe subsequent problems in functioning related to PTSS.    
While several studies with adults with HIV have emphasized high rates of PTSD 
and PTSS (Boarts et al., 2006; Brief et al, 2004; Brown, Lourie, & Pao, 2000), only one 
known study has suggested that behaviorally-infected adolescents and young adults with 
HIV experience PTSD and PTSS in response to both the diagnosis of HIV and other 
traumatic life events (Radcliffe et al., 2006).  Surprisingly, no known studies have 
investigated the presence of PTSS in perinatally-infected youth.  Furthermore, existing 
studies of PTSS in adults with HIV have conceptualized PTSS as resulting from non-
illness related traumatic events.  Kazak and colleagues’ (2006) model of PMTS, however, 
would suggest that youth with HIV may experience PTSS related to the experience of 
living with a life-threatening illness as well.   Thus, research regarding the prevalence of 
PTSD or PTSS in youth with HIV represents an important gap in the literature, 
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particularly as it may relate to the overwhelming problem of medication adherence in 
these populations.   
Adherence to HAART represents another major challenge for children and 
adolescents with HIV as well as a public health concern.   Research indicates that 
children and adolescents have adherence rates as low as 28% which can cause an increase 
in viral load and resistance to drug therapy (Armstrong et al., 2003; Brown, Lourie, & 
Pao, 2000; Reisner, Mimiaga, Skeer, et al., 2009).  In adult studies, PTSD 
symptomatology has been significantly related to adherence to HAART therapy (Boarts 
et al., 2006).   Recently, Radcliffe and colleagues (2006) presented findings suggesting 
that adherence was in fact significantly related to PTSD (Radcliffe et al., 2006).  
Additionally, while studies of adults living with HIV have emphasized the role of health 
beliefs such as internal locus of control orientation in contributing to adherence, this has 
yet to be explored in adolescents with HIV, particularly as it may relate to the impact of 
PMTS.  Specifically, research indicates that adults with HIV who perceive that their 
health is determined by their behavior (such as adhering to medication) show better 
medication adherence.  This research however, has not incorporated other correlates of 
adherence, such as PTSS.   
Uncovering the types and roles of trauma experienced by adolescents with HIV, 
as well as health beliefs associated with adherence could help lead to potential 
interventions geared towards improving adherence in this population and subsequently 
decrease morbidity and mortality.  The purpose of the proposed study is therefore to 
expand upon the literature regarding PTSD and PTSS in adolescents with HIV by 
exploring the presence of post-traumatic symptomatology in adolescents both 
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behaviorally and perinatally infected with HIV, and the relationship of post-traumatic 
stress to treatment adherence in this population. 
Aims and Hypotheses 
AIM I: To investigate the presence of posttraumatic stress symptoms in a sample of 
adolescents and young adults perinatally and behaviorally infected with HIV 
Hypothesis I: Both behaviorally-infected and perinatally-infected adolescents and young 
adults with HIV will endorse high rates posttraumatic stress symptomatology 
Additionally, posttraumatic symptoms will be present in response to both HIV and its 
related stressors, as well as other non-HIV related traumatic events.   
Kazak and colleagues’ (2006) empirically-based model of Pediatric Medical 
Traumatic Stress (PMTS) grew out of research which highlighted symptoms of post-
traumatic stress, namely intrusive thoughts, hyperarousal, and avoidance among pediatric 
samples.  According to their model, many potentially traumatic events (PTE’s) can occur 
in medical settings which may challenge beliefs about safety and invulnerability, and 
cause a potential life threat, feelings of fear and helplessness, and uncertainty regarding 
outcome.  These characteristics of medically-related events contribute in part to the 
development of symptoms, and may subsequently cause disrupted functioning and 
behavioral impairments.  The PMTS model would suggest that high rates of PTSS may 
exist for adolescents and young adults with HIV due to medically-related PTE’s.  In 
addition, research regarding adults with HIV, suggests that individuals with HIV have 
high rates of PTSD and posttraumatic stress symptoms (Boarts et al., 2006; Brief et al., 
2004; Brown, Lourie, Zlotnick, & Cohn, 2000) due to high rates of exposure to some 
type of traumatic events (Brief et al, 2004).   Radcliffe and colleagues (2006) documented 
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that adolescents and young adults behaviorally infected with HIV have high rates of 
posttraumatic stress.   
While there are no known published reports of posttraumatic stress in adolescents 
perinatally-infected with HIV, research regarding adjustment in children and adolescents 
perinatally-infected with HIV points to high rates of distress and poor psychosocial 
adjustment including internalizing and externalizing disorders (Boarts et al., 2006; Brief 
et al., 2004; Brown, Lourie, & Pao, 2000).   Indeed, in addition to PTE’s related to their 
HIV diagnosis, children and adolescents perinatally-infected with HIV frequently 
experience significant traumatic events such as the death of a parent or sibling (Brown, 
Lourie, & Pao, 2000).   Research has indicated that parentally bereaved children and 
adolescents exhibit moderate to severe levels of PTSD and exhibit more posttraumatic 
stress symptoms than survivors of environmental disasters or cancer (Harris, 1991; L. 
Stoppelbein & Greening, 2000; L. A. Stoppelbein, Greening, & Elkin, 2006).  Youth 
behaviorally-infected with HIV experience a range of traumatic events as well, both 
related to the experience of HIV and other life events (Radcliffe et al., 2007).  In 
particular, youth with HIV are likely to experience exposure to violent 
events/interpersonal violence which may lead to the development posttrauamtic stress 
symptoms (Kilpatrick et al., 2003; Martinez et al., 2009; Schwab-Stone et al., 1995).   
Furthermore, the diagnosis of HIV and its treatment clearly put an individual’s life and 
body integrity at risk (Radcliffe et al., 2006).   Therefore, it is expected that adolescents 
and young adults with HIV will exhibit high rates of posttraumatic stress irrespective of 
whether they acquired HIV through behavioral or perinatal infection.  Additionally, it is 
expected that they will experience posttraumatic stress in response to HIV-related PTE’s 
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as well as other traumatic life events.  This will extend prior findings which have focused 
solely on behaviorally-infected adolescents and have conceptualized post-traumatic stress 
as related to the high incidence of non-HIV-related traumatic life experiences noted in 
this population.  While high rates of PTSD are expected in this sample, it is expected that 
participants will endorse even higher rates of PTSS, as predicted by the PMTS model.   
AIM II:  To explore the relationship between posttraumatic stress symptomatology and 
adherence for adolescents and young adults with HIV.    
Hypothesis II: Posttraumatic stress symptoms will be associated with poor adherence.  
The PMTS model emphasizes that traumatic stress responses such as arousal, 
reexperiencing, and avoidance can become disruptive to functioning.  Specifically, 
psychological responses to PTE may affect treatment adherence such as in the case of 
PMTS-related avoidance (Kazak et al., 2006).  Studies involving adults with HIV have 
indicated that PTSD symptomatology is significantly related to poorer adherence to 
HAART therapy (Boarts et al., 2006).  Radcliffe and colleagues (2006) published 
findings with adolescents and young adults, which suggested that adherence was in fact 
significantly related to PTSD (Radcliffe et al., 2006).  It is therefore expected that 
individuals with PTSD or posttraumatic stress symptoms due to the HIV diagnosis will 
have high rates of poor adherence.   Further adult research suggests that posttraumatic 
stress symptoms and PTSD that results from non-HIV related traumatic events (such as 
childhood sexual abuse) is related to maladaptive or high-risk behaviors (Brief 2004; 
Miller, 1999; Reisner, Mimiaga, Skeer, et al., 2009).  It is, therefore, expected that 
adolescents and young adults who experience posttraumatic stress symptoms due to non-
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HIV related trauma will similarly show rates of poor adherence in a form of a high-risk or 
self-destructive behavior and poor self-care (Brief et al., 2004; Kimmerling et al., 1999).  
AIM III: To investigate the role of health locus of control in the association of PTSS 
with treatment adherence. 
Hypothesis III:  Internal health locus of control will moderate the association of PTSS on 
adherence, such that increased internal health locus of control will weaken the 
relationship of PTSS with poor adherence. 
The Health Belief Model, and its associated health locus of control construct, 
guided prior research investigating correlates of treatment adherence in HIV, indicating 
that individuals who adhere to treatment for HIV tend to have a high internal health locus 
of control orientation (i.e. they believe in their ability to impact their health through their 
own behavior) (Chesney et al., 2000; Molassiotis et al., 2002; Wallston & Wallston, 
1978).  While this research has been conducted largely on adult samples, less is known 
about the role of health locus of control orientation in pediatric samples, although a few 
studies have indicated that health beliefs may predict adherence for adolescents with HIV 
(Belzer, et al., 1999; Reddington et al., 2000).  
As stated above, is expected that adolescents and young adults who experience 
PTSS due to HIV-related and non-HIV related trauma will demonstrate poor adherence to 
both medication and clinic visits.  The PMTS model emphasizes the role of beliefs 
associated with a medical illness and its treatment in psychosocial functioning.  In 
accordance with this model and the health locus of control construct, it is expected that 
maintaining a high internal locus of control orientation will moderate the effect of PTSS 
on adherence.   
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CHAPTER 3. METHODS 
Participant Recruitment 
Participants recruited for this study included adolescents and young adults between the 
ages of 12-21 who were HIV positive and received care at the Immunology Clinic at St. 
Christopher’s Hospital for Children in Philadelphia, Pennsylvania.  The clinic provides 
multidisciplinary care for HIV positive infants, children, adolescents, and their mothers.  
Medical, nutritional, mental health and case management services are provided to approximately 
300 individuals.  At the time of recruitment, the clinic population included about 140 youth with 
a mean age of 12.  Ninety-five percent of the patient population were ethnic minorities, and 
regarding ethnicity, two-thirds were African American and one-third was Latino/a.  The male to 
female ratio was about 50%.  Two-thirds of the patient population contracted HIV infection 
through perinatal infection, while one-third of the population were behaviorally infected or 
“newly diagnosed”.  Patients were expected to attend regular clinic appointments every 1-2 
months.  
Patients were eligible for participation if they were between 12 and 21 years of 
age, and behaviorally or perinatally infected with HIV. Due to the focus of some 
measures on posttraumatic stress symptoms in response to HIV, only patients identified 
as being informed of their HIV diagnosis were included in the study.   Patients not on 
treatment at the time of recruitment, as well as who were prescribed HAART, were 
eligible for the study as it was determined that individuals not on medication still have a 
number of treatment requirements (e.g., attending clinic and outside appointments, 
completing lab work, completing home visits) to which they must adhere.  Patients were 
 45 
excluded from participation if they did not speak English or were not able to read and 
understand the consent documents.  
Potential patients, identified by clinic staff, were recruited for the study during 
regularly scheduled clinic appointments.  When possible, caregivers were contacted by 
clinic staff to ask that they accompany their children to their next clinic visit so that they 
may learn about participating in a study geared towards understanding why some patients 
may have difficulty adhering to their treatments or keeping medical appointments.  (This 
methodology was suggested by Chesney et al. (2000) to increase the validity of self-
reported adherence.)  Caregivers who accompanied adolescents (ages 12-17) to their 
scheduled appointments were approached by the first author or a trained graduate 
research assistant and asked to participate in the study. Once a caregiver gave permission 
for the research assistant or first author to discuss the study with a patient, the adolescent 
was approached and details of the study were explained to them. Patients ages 18 and 
older were approached directly about participation in the study.   All participants were 
compensated for their time with a gift certificate ($10 value) provided by grant funding 
available to the immunology clinic.      
Participant Description 
 Total sample. There was a combined sample of 28 participants.  Table 1 describes 
the demographic characteristics of the sample. Of those 28 participants, 43% (12) were 
between the ages of 12 and 17, and 57% (16) were between the ages of 18 and 22.  Forty-
six percent (13) were perinatally infected, and 54% (15) were behaviorally infected.  
Overall, fifty-four percent (15) of the participants were male, and 46% (13) were female.   
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The ethnicity breakdown of the overall participant pool was as follows: 61% (17) African 
American, 18% (5) Hispanic, 14% (4) Caucasian, 3.6% (1) Haitian, and 3.6% (1) 
Biracial. The mean number of clinic appointments scheduled over a 6 month period for 
the total sample was 5.32 (SD =2.3, range = 2-13). At the time of consent, 75% of 
participants (21) were on medication, and 25% (7) were not.   As 140 patients were 
identified as potential participants, the participation rate for this study was 20%.   
 With regard to the adherence variables (Table 2), the average %CD4 Count for 
the combined sample was 29.19 (SD = 9.02, range = 14.25 - 45.50).  Only four 
participants (14%) had a %CD4 below 20%.  The average log viral load count for the 
sample was 1.54 (SD = 1.63, range = 0.00 - 4.43).  Nine participants (32%) had a log 
viral load level of 3 or greater, and 3 participants (11%) had a log viral load level of 4 or 
greater.   In general, a log viral load of less than 1.70 is undetectable, 1.70-4.0 is low, 4.0-
5.0 is intermediate, and greater than 5.0 is high.  The average provider rating score was 
5.00 (moderately adherent) (SD = 1.54, range = 2.00-7.00).   Ten participants (36%) 
received a rating of 4 or below (out of a possible 7), while 6 participants (21%) received a 
score of 7. 
 Perinatal group.  Fifty-four percent (7) of the perinatal group was male, and 46% 
(6) of the perinatal group was female.  The ethnicity breakdown of the perinatal group 
was as follows: 39% (5) African American, 31% Latino (4), 23% (3) Caucasian, and 8% 
(1) other.  The mean number of clinic appointments scheduled for the perinatal group was 
4.70 (SD = 1.6, and, range = 2-7).  At the time of consent 85% of the perinatal group was 
on medication. 
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 Behavioral group.  Fifty-three percent (8) of the behavioral group was male and 
47% (7) was female. The behavioral group’s ethnicity breakdown was: 80% (12) African 
American, 7% (1) Latino, 7% (1) Caucasian, and 7% (1) other.  With regard to the mean 
number of clinic appointments, the behavioral group had 5.87 (SD = 2.9, range = 2-13).  
At the time of consent, 67% of the behavioral group was on medication.  
Comparability of the two samples.  The feasibility of pooling together the two 
sample groups in the study (behaviorally infected and perinatally-infected) was 
examined.  Differences based upon transmission group were reviewed via t-tests and chi-
square analyses (Tables 2 & 3).  No significant differences in %CD4 count, Viral Load, 
Trauma symptom severity (for both HIV-related and non-HIV-related traumas), or scores 
on Internal Health Locus of Control (IHLC) were found between the behavioral and 
perinatal samples.  Additionally, a chi-square analysis found that neither perinatally-
infected nor behaviorally-infected participants were more likely to be prescribed HIV-
related medications at the time of consent.  The perinatally-infected sample was found to 
have significantly younger participants than the behaviorally-infected sample [t(20) = -
6.8, p < .001] with the perinatally-infected participants having an average of 14.5 years 
of age (SD  = 2.22) and the behaviorally-infected sample having a mean age of 19.4 years 
(SD = 1.40) (see Table 1).   Other than this noted difference, there were no significant 
differences based upon route of transmission; therefore, it was deemed appropriate to 
combine these samples in subsequent analyses. 
 A two-way between groups ANOVA was run to determine the feasibility of 
pooling trauma data from the younger and older groups and perinatally and behaviorally-
infected groups.  This was done for both HIV-related and non-HIV related trauma data.  
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The analyses explored the impact of developmental level and mode of HIV transmission 
on levels of PTSS. Results revealed no significant differences in PTSS scores regardless 
of developmental level (adult versus child), their mode of transmission (perinatal versus 
behavioral) or their interaction.  T-test analyses were used to determine the feasibility of 
pooling trauma data from males and females.  Separate t-test analyses examining HIV-
related trauma data and non-HIV related trauma data were performed.  No significant 
differences were found in gender. Therefore, it was determined appropriate to combine 
trauma data from both the younger and older participants and males and females. 
Measures 
 Demographic and adherence variables.  Demographic and adherence-related 
variables were assessed through a medical file review. Data recorded from 1-year prior to 
consent up to the consent date was collected.  Demographic variables included: age, 
gender, and race/ethnicity. Disease-related variables included: current biological disease 
markers (CD4 T-cell counts and viral load counts), an average count of biological 
markers over the past year, prescribed medications, and resistance to medication ratings.   
  Adherence was assessed via a multi-dimensional format.  First, biological 
markers of adherence including CD4 counts and viral load counts (both current and 
yearly averages from the time of consent) attained from medical file review were used as 
physiological measures of adherence (Table 3).  Viral Load level values were recorded, 
transformed into Log values, and averaged.  Percent CD4 values for the year were 
summed and then averaged.  Secondly, percentage of appointments over the 6 months 
prior to consent was obtained from medical file review.  
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 Third, a global provider rating scale used by Radcliffe and colleagues (2006) was 
collectively administered to the medical treatment team during clinic rounds/meeting 
times.  This scale provides a single global rating of adherence and provides the following 
prompt: “In the past six months, how would you rate the individual’s participation in 
their HIV care on the following categories: Appropriate follow through with 
recommended medication regimen, completes all required lab tests, follows through with 
appointments outside of this clinic, completes scheduled home visits”.  Providers selected 
each participant’s overall adherence rating from a Likert-type rating scale (1-7).   All 
responses were then summed and averaged.  Providers also indicated the area in which 
the participant is most successful, and the area in which the participant is least successful.  
 Life stressors.  The Life Experiences Survey (LES-N; (Sarason, Johnson, & 
Siegel, 1978; Sarason, Sarason, Potter, & Antoni, 1985) was used to assess negative life 
events experienced by participants and to provide a prompt for completing the trauma 
questionnaires.  The LES is a 57-item self-report measure that assesses general stressful 
life events and provides a quantification of perceived impact of those events.  For the 
purposes of this study, participants were prompted to indicate whether they had 
experienced the given events in their lifetime.  Participants rated separately the 
occurrence, desirability, and impact of events by indicating the events they experienced, 
whether they viewed the event as being positive or negative, and the perceived impact of 
the event on their life at the time it occurred.  Ratings range from extremely negative to 
extremely positive on a 7-point scale.  Since each participants’ score will be based on a 
different set of independent items (depending on what he/she rates as positive or 
negative) a reliability score for this scale will not be calculated.   
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 Posttraumatic stress.  The Posttraumatic Diagnostic Scale (PDS; Foa, Cashman, 
Jaycox, & Perry, 1997) is a measure used to assess both the presence of a PTSD 
diagnosis and PTSD symptom severity in accordance with DSM-IV PTSD criteria.   It 
contains two parts. The first part is a checklist of 12 traumatic events (including an 
“other” category) in which participants indicate the events they have witnessed or 
experienced.  In the second part, participants describe which event was most disturbing to 
them in the past month and are asked to describe the event and refer to it in subsequent 
sections.  Individuals then complete 17 items regarding symptoms of reexperiencing, 
avoidance, and arousal.  Next, 9 items assessing impairment of functioning in different 
areas of life are administered.  In order for a diagnosis of PTSD to be met, an individuals’ 
response must include: the presence of physical injury or perception of a life threat, a 
sense of helplessness or being terrified by the event, and endorsement of at least one 
reexperiencing symptom, three avoidance symptoms, and two arousal symptoms.  
Symptom duration must be at least 1 month and accompanied by an impairment of 
functioning in one area. The measure yields a Total Symptom Severity score (sum of 17 
items) and Reexperiencing, Avoidance subscale and Arousal subscale scores.   
 The measure was validated on 248 adults who experienced a wide variety of 
traumas (e.g., accident, fire, natural disaster, assault, and combat) and demonstrated high 
internal consistency and test-retest reliability, high diagnostic agreement with the SCID, 
and good sensitivity and specificity. It is widely considered to be a useful screening tool 
for PTSD in research settings (Foa et al., 1997).  It was used with participants ages 19 
through 21.  The scale was administered twice to participants in order to assess PTSD 
related to HIV and PTSD related to another life event.  In order to counterbalance 
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responses to this measure, half of the participants were asked to first identify the worst 
non-HIV related event that happened to them and then completed it a second time for 
HIV.  The other half of the participants completed this measure in the reverse order.     
 There was an error made by this author, and an item on the subscale of Avoidance 
was omitted.  This was conceptualized as a systematic missing data problem.  In order to 
reconcile this error and mitigate its effects on the study, it was decided that in place of 
calculating a Total Symptom Severity Score from the total scores from all the subscales, 
an average score for each subscale would be obtained.  Using this average, an Average 
Symptom Severity score was obtained in place of a Total Symptom Severity score and 
used for analyses.  In order to streamline data analyses and be able to compare both the 
child and adult versions of this measure, this was done for data from both the 
Posttraumatic Diagnostic Scale (PDS) and Child PTSD Symptom Scale (CPSS) 
(described below), for both general and HIV-related traumas. 
 For the purposes of this study, the average Total Symptoms Severity score was 
used in primary analyses and for Hypotheses 1, 2 and 3.  Follow-up analyses described in 
later sections incorporated the subscale scores in order to evaluate specific symptoms 
seen in the population.  The inter-item reliability of the Total Symptom Severity score 
reported by Foa and colleagues (1997) was 0.92.   For this study, the inter-item reliability 
of the average Total Symptom Severity scores for both HIV-related traumas and non-HIV 
related traumas were 0.95 and 0.91 respectively. 
The Child PTSD Symptom Scale (CPSS; Foa, Johnson, Feeny, & Treadwell, 
2001) is a self-report measure used to assess PTSD diagnosis and the severity of PTSD 
symptoms in children and adolescents ages 8 to 18 in accordance with DSM-IV PTSD 
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diagnostic criteria.  The scale is based on the adult PDS, and contains two parts.  The first 
part contains 17 items which measure PTSD symptomatology through a 4-point Likert 
scale and yield a total Symptom Severity score. The second part contains seven additional 
items which assess daily functioning and functional impairment and are scored 
dichotomously as either present or absent.  The scale also yields severity scores for each 
of the three symptom clusters: Reexperiencing, Avoidance, and Arousal.  
 The measure was validated on 75 school age children (ages 8-15) who had 
experienced the 1994 Northridge, California earthquake.  It demonstrated high internal 
consistency and test-retest reliability for both the total score and three subscales, and 
demonstrated high internal consistency and test-retest reliability, high diagnostic 
agreement with the SCID, and good sensitivity and specificity.  Preliminary analyses 
suggest that this is a useful tool for the assessment of posttraumatic stress symptoms and 
PTSD in children and adolescents.  Inter-item reliability for the total score was reported 
as 0.89 by Foa and colleagues (2001).   For this study, the inter-item reliability of the 
Total Symptom Severity scores on the CPSS for HIV-related traumas was 0.87 and 0.89 
for non-HIV related traumas. 
The scale was used with participants ages 12-18.  As with the PDS, it was 
administered twice to participants in order to assess posttraumatic stress symptoms 
related to HIV and symptoms related to another traumatic life event.  In order to 
counterbalance responses to this measure, half of the participants were asked to first 
identify the worst non-HIV related event that happened to them and then completed it a 
second time for HIV.  The other half of the participants will complete this measure in the 
reverse order.   As previously explained, it was decided that in place of calculating a 
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Total Symptom Severity Score from the total scores from all the subscales, an average 
score for each subscale would be obtained for consistency in scoring adult and child 
PTSD measures.  
Despite best efforts from research assistants to collect comprehensive data from 
every participant, several participants declined to complete the CPSS questionnaires, 
stating that they had not experienced any traumatic events.   Additionally, one individual 
selected an HIV-related event for the non-HIV related trauma questionnaire and this 
participant’s non-HIV related CPSS questionnaire was therefore pulled from the dataset. 
Therefore, valid CPSS data for HIV-related traumas was collected from only 7 out of 12 
participants, and valid data for non HIV-related traumas was obtained from 6 
participants.  Additionally, one person completed the measure for HIV who did not 
complete it for non-HIV related traumas and one individual completed the measure for 
non-HIV related traumas who did not complete it for HIV-related traumas.  
 Health locus of control.  The Multidimensional Health Locus of Control Scale 
(MHLC; Wallston, Wallston, & DeVellis, 1978) is used to assess general health locus of 
control (LOC), in particular an individual’s belief that general health is or is not 
determined by personal behavior.  The MHLC is an 18-item self-report questionnaire that 
measures 3 dimensions of LOC (Internal, Powerful Others, Chance) related to health.  A 
6-point Likert-type scale ranging from 1 (strongly disagree) to 6 (strongly agree).  Each 
dimension has 6 items that produce a possible range of scores of 6 to 36 per scale.  The 
MHLC has been found to be empirically valid and reliable, including the Internal Health 
Locus of Control (IHLC) (α = .77).   For this study, only the Internal Health Locus of 
Control (IHLC) score was used and yielded a similar reliability score (α = .73).  
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 Debriefing interview.  In order to systematically determine whether participants 
became distressed in completing the forms, adolescents were asked to complete the 
Reactions to Research Participation Questionnaire for Children (RRPQ-C; Kassam-
Adams & Newman, 2002). The RRPQ-C is a short “debriefing” interview in which 
participants are asked about their thoughts and feelings regarding participation in the 
study.  The RRPQ-C also allows the investigator to determine whether a participant 
experienced any distress during the assessment, whether a participant might be suffering 
from posttraumatic stress symptoms, and provide referrals for treatment if needed.  The 
RRPQ-C usually takes a few minutes to complete.  The RRPQ-C was administered after 
all of the measures were completed.   
Procedure 
Prior to recruitment of participants, approval of the full study protocol by the 
Institutional Review Board (IRB) at Drexel University was obtained. All discussions 
regarding the study and data collection took place in a private room.  After obtaining 
caregiver permission, assent was obtained from adolescents.  Adolescents ages 18-21 
were approached directly.  Prior to obtaining consent/assent, the basic purpose of the 
study as well as further explanation of the risks, and benefits were provided.  Assessment 
packets were completed during regularly scheduled clinic visits.  Questionnaires took 
approximately 30 minutes to complete.  The debriefing interview was conducted last in 
order to wrap up the assessment, as well as determine whether a participant experienced 
any level of distress and provide referrals.  No participant endorsed experiencing distress 
as a result of participation in the study.   In one instance, a participant was identified as 
endorsing some suicidal ideation. Permission to discuss findings with the participants’ 
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medical team was obtained and this participant was identified to the medical team and 
subsequently followed for psychosocial care.  After assessments were completed, medical 
file reviews were conducted by the principle investigator and trained research assistants 
Data Analysis Plan 
 An SPSS database was created including all relevant demographic, medical and 
assessment information.  Data were analyzed using a .05 probability level as the standard 
measure of significance. Power was calculated using both the method described by 
Algina and Olejnik (2003) for correlations and partial correlations as well as through 
G*PowerTM.  
The sampling distribution was examined for the following variables: clinical 
provider rating of adherence, average percent CD4 count (%CD4), average log viral load, 
average trauma symptom severity (for non-HIV traumas), and average trauma symptom 
severity for HIV-related trauma.  
Correlations between demographic and adherence variables and between LES 
negative life events and adherence variables were performed in order to determine 
whether any variables should be controlled for in future analyses. Correlations between 
adherence variables were also performed   
Hypothesis I.  Both adolescents and young adults behaviorally and perinatally-
infected with HIV would endorse symptoms of posttraumatic stress (PTSS) and that 
PTSS would be related to both non-HIV related potentially traumatic events and HIV-
related potentially traumatic events.  Descriptive frequency analyses were run to explore 
the frequencies of the Total Trauma Severity scores.  
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Hypothesis II. Posttraumatic stress symptoms would be significantly correlated 
with poor adherence.  Pearson correlations between adherence variables and 
posttraumatic stress symptom severity (Total Trauma Severity scores) were run for both 
HIV-related traumas and non-HIV related traumas.  Developmental level and gender 
were controlled for in appropriate analyses.  
Hypothesis III. Internal health locus of control (IHLC) would moderate the effect 
of posttraumatic stress on adherence, such that increased IHLC would weaken the 
relationship of post-traumatic stress symptoms on adherence.  Although it was this 
author’s original intention to run a moderation analyses as put forth by Baron and Kenny 
(1986) and Holmbeck (1997), a moderation analyses was not run because the statistical 
power for this analysis was found to be too low given the number of participants.  
Therefore, the likelihood of detecting a significant result was too low.  Instead, partial 
correlations between adherence variables and trauma symptom severity controlling for 
IHLC were run in order to explore potential indirect effects of IHLC on the relationship 
between adherence and posttraumatic stress.  Pearson correlations among IHLC, 
posttraumatic stress symptom severity and adherence variables were also run. 
Follow-up analyses.  Follow-up exploratory analyses were conducted to 
determine which types of PTSS participants endorsed (reexperiencing, avoidance, 
arousal) the most.  Additionally, an ANOVA was conducted for both HIV-related and 
non-HIV related data to determine whether there was a significant difference between 
means on trauma subscales scores.   
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Follow-up analyses were also conducted to explore results from the RRPQ-C in 
order to determine how many participants reported positive and negative appraisals 
regarding their participation in the study.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 58 
CHAPTER 4. RESULTS 
Preliminary Analyses   
 Power analyses.  Hypotheses II yielded power ranging from .06 to .61 for 
correlations and partial correlations.  Hypothesis III had a power ranging from .06 to .55.   
As Hypothesis I used only frequencies for the analyses, no power calculation was 
performed.  
Sampling distribution of variables. Tests of normality including histograms and 
normal probability plots indicated that the clinical provider rating of adherence variable, 
average percent CD4 count, average trauma symptom severity (for non-HIV traumas), 
and average trauma symptom severity (for HIV-related traumas) met the assumptions of 
normality. 
 Average log viral load did not meet the assumption of normality as the 
Kolmogorov-Smirnov statistic was significant.  The variable’s distribution was positively 
skewed, with a high number of cases having a viral load of 0, and skewness was negative.  
The variable was transformed to correct the distribution by adding 1 to the original 
variable and then taking its square root. 
  “Percentage of Appointments Kept” was not a viable variable of adherence since 
a wide and inconsistent range was found in number of appointments scheduled over the 
year prior to participation. Furthermore, Percentage of Appointments kept was not 
associated with other variables of adherence.  “Percentage of Appointments Kept” was 
not used in the analyses.  
 Correlations between demographic and adherence variables. Preliminary 
analyses involving the correlation of demographic variables with adherence variables 
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were performed in order to determine whether any variables should be controlled for in 
subsequent analyses.  Age and ethnicity yielded no significant correlations with measures 
of Average Viral Load count, %CD4 count, and Provider Rating of Adherence.   T-test 
analyses were also run to examine differences for both gender and developmental level 
(whether an individual was an “adult” or “child”) on adherence variables.  With regard to 
gender, males (M = 5.73, SD = 1.16) were rated significantly better than females (M = 
4.15, SD = 1.52) by clinical provider ratings of adherence [t(26) = 3.11, p = .004].  With 
regard to developmental level, younger participants (M = 0.75, SD = 1.33) had a 
significantly lower Average Viral Load counts than older participants (M = 2.14, SD = 
1.62); [t(26)= -2.41, p = .023].   Younger participants (M = 5.75, SD = 1.42) were also 
found to do better on clinical provider ratings of adherence than older participants (M = 
4.44, SD = 1.41); [t(26) = 2.43, p = .023].  No significant difference was found between 
older and younger participants on the variable of %CD4 count.   It was therefore 
determined that developmental level and gender would be employed as covariates in 
appropriate analyses.    
 Correlations between LES negative life events and adherence variables were also 
performed in order to determine whether negative life events should be controlled for in 
subsequent analyses.   None of the adherence variables were found to be significantly 
correlated with negative life events.  Correlations between LES negative life events and 
PTSS severity were also run for non-HIV traumas and HIV-related traumas.  Negative 
life events were significantly correlated with PTSS severity for non-HIV related traumas 
(r = 0.54, p = .012) and HIV-related traumas (r = 0.60, p = 0.003). 
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 Correlations among adherence variables.  From correlations among the three 
adherence variables, a significant negative correlation between Log Viral Load and 
Provider Rating of Adherence was found (r = -.59, p = .001).  A medium negative 
correlation between Log Viral Load and %CD4 trended to significance (r = -.37, p = 
.066).   No significant correlation was found between Provider Rating of Adherence and 
%CD4.   
Description of Study Variables 
 Scores on psychological variables are reported in Table 3.  In order to compare 
participants’ results on the PDS and CPSS with that of published normative data, the 
published normative data was also converted into average scores.  The PDS measure was 
normed on 248 adults who experienced a wide variety of traumas (e.g., accident, fire, 
natural disaster, assault, and combat) (Foa et al., 1997).  While Total Symptom Severity 
scores and Reexperiencing scores for HIV-related trauma were slightly lower than those 
reported in the normative sample, scores on the Avoidance and Arousal subscales were 
similar to those of the normative sample.  With regards to the non-HIV related trauma 
data, all scale scores were slightly lower than normative value except for the Arousal 
subscale scores  which were similar to those of the normative sample.   
 The CPSS measure was validated on 75 school age children (ages 8-15) who had 
experienced the 1994 Northridge, California earthquake (Foa et al., 2001).  With regard 
to the CPSS, scores for both general and HIV-related traumas tended to be higher than 
published normative data.   
 On the Multidimensional Health Locus of Control Scale (MHLC), this sample 
endorsed higher internal locus of control scores than published normative data (Wallston 
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et al., 1978).  This measure was originally normed on a non-clinical sample of 115 people 
ages 16 and over who were waiting at gates in a metropolitan airport.   
Examination of Hypotheses 
 Hypothesis 1: Participants would endorse symptoms of posttraumatic stress 
associated with both HIV and general life traumas.  For general trauma (non HIV-related) 
from the PDS and CPSS, results indicated that 21 participants (75%) reported 
experiencing at least one traumatic event.  Fourteen participants (61%) endorsed 
experiencing at least a “moderate” average total trauma symptom severity or greater, 7 
participants’ data (30%) fell in the “moderate-severe” range, and one individual (4%) was 
rated as “severe”.  Events nominated as potentially traumatic events by participants listed 
in order of frequency (from most frequent to least frequent) included:  the death of a 
loved one, death of a parent specifically, being removed from a caregiver, being placed in 
foster care, accident/injury, family violence, moving away from family, relationship 
difficulties, family conflict, and school-related stress. 
  With regard to HIV-related traumas, 23 participants (82%) reported experiencing 
at least one HIV-related traumatic event.  Fourteen participants (64%) had a trauma 
symptom severity score in at least the “moderate” range or greater, 6 (27%) participants 
had scores in the “moderate-severe” range, and 3 (14%) participants had scores in the 
“severe” range.  Events nominated as potentially traumatic events by participants in order 
of frequency included:  receiving the HIV diagnosis, stigma-related to having HIV, 
worries about the disease, taking medication, physical effects of the disease and its 
treatment.       
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 The mean trauma symptom severity score for HIV-related traumas was 1.14 (SD 
= 0.84), falling in the moderate level of trauma symptom severity.  The mean trauma 
symptom severity score for non-HIV related traumas was also in the moderate range (M = 
0.81, SD = 0.67).  Comparison of the average trauma symptom severity scores for HIV-
related and non-HIV related data showed that for 64% of participants, the HIV-related 
traumatic event was more traumatic than the non-HIV related traumatic event.   However, 
a one-way ANOVA detected no significant difference in the average total symptom 
severity scores for HIV and non-HIV related traumas [F(1, 43) = 1.41 , p =  0.241].    
 Hypothesis II: Posttraumatic stress symptoms would be significantly correlated 
with poor adherence.   Given that developmental level was associated with viral load 
levels, and both developmental level and gender were associated with provider rating of 
adherence, both developmental level and gender were controlled for in appropriate 
analyses.  In summary, the provider rating of adherence variable was significantly 
correlated with trauma symptom severity for non HIV-related trauma and  showed a trend 
to significance in the correlation with trauma symptom severity for HIV-related trauma.  
Viral load also showed a trend to significance in the correlation with trauma symptom 
severity for non HIV-related trauma (see Table 4).   Hypothesis II was partially 
supported.  
 Hypothesis III: IHLC will have an indirect effect on the relationship between 
treatment adherence and posttraumatic stress symptom severity.   IHLC was not 
significantly correlated with Adherence variables or posttraumatic stress symptom 
severity (see Table 4).  Partial correlation was used to explore the relationship between 
treatment adherence variables and posttraumatic stress symptom severity while 
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controlling for IHLC scores (see Table 5).  These analyses also controlled for the effects 
of developmental level and gender of the participants where appropriate.  The partial 
correlation between Provider Rating of Adherence and Posttraumatic Stress Symptom 
Severity for non-HIV related trauma, controlling for IHLC was significant, r = -0.47, p = 
0.047.  However, inspection of the zero order correlation calculated for Hypothesis II (r = 
-0.48, p = 0.038) suggested that controlling for IHLC did not influence the relationship 
between the two variables.   Similarly, while the partial correlation between Provider 
Rating of Adherence and Posttraumatic Stress Symptom Severity for HIV-related trauma 
exhibited a trend to significance while controlling for IHLC, r  = -0.42, p = .074, 
inspection of the zero order correlation (r = -0.43, p = 0.060) suggested that controlling 
for IHLC did not influence the strength of the relationship between these two variables. 
 Exploratory Analyses. Exploratory analyses were run to determine which 
component of posttraumatic stress (reexperiencing, arousal, or avoidance) participants 
endorsed the most.  For both non-HIV and HIV-related traumas, participants endorsed 
reexperiencing symptoms the most.  The mean average reexperiencing symptoms for 
non-HIV and HIV-related traumas respectively were 0.83 (SD = 0.79) and 1.22 (SD = 
0.99).  Next, mean average avoidance symptoms for non-HIV and HIV-related traumas 
respectively were 0.81 (SD = .73) and 1.17 (SD = 0.92).  Then, mean average arousal 
symptoms for Non-HIV and HIV-related traumas respectively were 0.80 (SD = 0.77) and 
1.01 (SD = 0.93).  A one-way ANOVA was run to explore differences between trauma 
subscales scores endorsed.  This analysis did not reveal a significant difference between 
means on trauma subscale scores for either non-HIV or HIV-related trauma data. 
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 Exploratory frequency analyses were also run to explore participants’ reactions to 
research as assessed via the RRPQ-C.  Results indicated that the majority of participants 
endorsed positive appraisals regarding their research participation.  Specifically, 79% of 
participants were glad they were in the study (endorsed “yes”), 43% of participants felt 
good about themselves as a result of participating, and 71% felt good about helping 
others through their participation.  With regard to negative appraisals, 1 participant (4%) 
found the study “boring’, no participants endorsed “yes” to feeling upset or sad by their 
participation, 14% endorsed “maybe” feeling upset or sad by their participation, and only 
1 participant (4%) was sorry to be in the study.  Ratings regarding trust in the informed 
consent process ranged from 86%-93%.    
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CHAPTER 5. DISCUSSION 
 The present study aimed to expand upon the current research exploring problems 
related to treatment adherence among children and young adults with HIV.  (Armstrong 
et al., 2003; Murphy et al., 2005; Radcliffe et al., 2006; Simoni et al., 2007).   In 
particular, this study examined posttraumatic stress and the role of health locus of control 
as factors associated with reduced treatment adherence.  
 The first hypothesis examined the rates of posttraumatic stress symptoms in 
adolescents and young adults with HIV.  Results indicate that this study’s sample of 
young people with HIV exhibited higher rates of posttraumatic stress than the general 
population.  Participants reported experiencing posttraumatic stress both in regard to 
general life stressors and HIV-specific stressors.  The second hypothesis examined the 
relationship between posttraumatic stress symptoms and adherence variables.  An inverse 
relationship between posttraumatic stress and provider rating of adherence was found (for 
both non HIV-related and HIV related traumas).  A relationship between posttraumatic 
stress from non-HIV related traumatic events and viral load was found trending to 
significance.  The third hypothesis examined whether Internal Health Locus of Control 
(IHLC) indirectly affected the relationship between posttraumatic stress and treatment 
adherence.  IHLC was not found to have an impact on this relationship.  Recruitment 
difficulties in this study yielded a small sample size and subsequently the ability to 
identify medium effects was limited by low power.  Additionally, the sample used in this 
study was found to be relatively healthy, thus yielding little variability in the data and 
further limiting the analyses through restriction of range.  Overall, results of this study 
highlight the importance of devising treatment interventions that focus on posttraumatic 
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stress in order to improve treatment adherence.  The need to further investigate the role of 
health beliefs in adherence and improve the measurement of adherence is discussed.   
Review of Results 
 Posttraumatic stress.  The majority of participants in this study reported having 
experienced at least one HIV-related event and one non HIV-related traumatic event.   
This finding is similar to, although slightly lower than, previous findings of Radcliffe and 
colleagues (2007) and higher than reported rates of traumatic events in the general 
population (Cuffe et al., 1998; Giacconia et al., 1995).   Furthermore, while a 
measurement error made by this author made it impossible to calculate the prevalence of 
a PTSD diagnosis specifically, results indicated that overall, adolescents and young 
adults with HIV in this sample experienced posttraumatic stress symptoms (both relating 
to HIV and non-HIV related traumatic events) at higher rates than what might be 
expected to be found in the general population (Cuffe et al., 1998; Giacconia et al., 1995).    
These results are consistent with reports of high rates of PTSD among adults with HIV 
(Boarts et al., 2006;, Brief et al., 2004; Katz & Nevid, 2005).  Given the small sample 
size of the study, and the fact that there is so little currently known about PTSS and 
PTSD among adolescents and young adults with HIV, these results are particularly 
noteworthy and carry important clinical implications.   
 Another interesting finding, although not a primary question of this research, was 
the fact that behaviorally-infected and perinatally-infected adolescents experienced 
posttraumatic stress symptoms to the same degree.   Prior research regarding 
posttraumatic stress and HIV has focused on adults and youth behaviorally-infected with 
HIV and not those perinatally-infected.   These populations have been conceptualized as 
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experiencing very different challenges.  Our findings suggest that they may be more 
similar than previously thought.  Specifically, although these groups may experience 
different types of stressors (such as the death of a parent from HIV among perinatally-
infected youth), the negative life events associated with environmental and demographic 
factors (low SES, chronic poverty, ethnic minority status) may impact these two 
populations equally.  Furthermore, the stressors that overlap in the two groups (such as 
the stigma associated with HIV) may be more influential than the stressors that differ 
between them.    
 The fact that no difference was found for adolescents versus young adults for 
trauma scores was equally remarkable and contrary to what is reflected in the pediatric 
cancer literature.  Research exploring survivors of childhood cancer highlights the 
importance of developmental level in the development of posttraumatic stress symptoms, 
as young adults who survived cancer as children display higher rates of trauma symptoms 
than children survivors (Hobbie et al., 2000).   It is therefore interesting that in a 
population in which the onset of HIV occurred during differing developmental levels for 
different individuals (i.e. some perinatally-infected individuals have been grappling with 
HIV since birth and other behaviorally-infected individuals since adolescence or early 
adulthood) there should be similar rates of posttraumatic stress.  While this finding may 
be the result of low power, it suggests that further research is needed regarding the impact 
of development on trauma processing in cases where trauma does not resolve such as 
with HIV. 
 Posttraumatic stress and adherence.  The relationships found between PTSS 
(both HIV and non-HIV related) and provider ratings of adherence and between PTSS 
 68 
and viral load are particularly noteworthy given the limited power of this study.   These 
findings carry important clinical implications and suggest that providers are noticing the 
ways in which the mental health of a patient impacts the patient’s ability to engage in 
self-care and to follow up with prescribed care regimens.  The strong correlation found 
between provider ratings of adherence and viral load however, suggests that providers’ 
ratings of adherence may also be based at least in part on the knowledge they have of 
their patients’ viral load levels.  Taken together, these results provide partial support for 
the relationship between PTSS and nonadherence and highlight the importance of care 
providers being more aware of the traumatic nature of HIV and other negative life events. 
 The exploratory analysis finding of no significant difference between means on 
trauma subscale scores for either HIV-related or non-HIV related trauma data was 
surprising, as it was theorized that the presence of avoidance and reexperiencing 
symptoms in particular would have the most significant adverse effect on treatment 
adherence.  It was theorized that avoidance symptoms relating to HIV in particular might 
lead to a failure to adhere to treatment regimens as well as an avoidance of medical 
appointments or any reminders of having HIV.  Similarly, individuals with 
reexperiencing symptoms related to HIV might feel distressed at revisiting the site of 
their diagnosis or treatment, and therefore maintain poor adherence (Radcliffe et al., 
2007).  Results indicate, however, that these individuals are experiencing the different 
PTSS symptoms to the same degree.  
 Internal health locus of control. The third hypothesis examined the role of IHLC 
and found no indirect effect for IHLC on the relationship between PTSS and treatment 
adherence .  It did not appear that a sense of personal control over health was related to 
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an individual’s ability to maintain treatment adherence, nor did it seem that a sense of 
personal control affected the impact of trauma on an individual’s ability to adhere to 
medical care regimens.   Given the applicability of the Health Belief Model (HBM) in 
predicting adherence behaviors in adults and adolescents behaviorally-infected with HIV 
(Belzer et al., 1999; Chesney et al., 2000; Molassiotis et al., 2002; Muma et al., 1995), it 
was expected that that HLC, a construct closely linked to the HBM, would be useful in 
furthering the understanding of treatment adherence in youth with HIV.  The lack of a 
significant finding for the affect of IHLC on the relationship between posttraumatic stress 
and adherence suggests that IHLC may be too simplistic a construct to explain or predict 
adherence in this population.  Similarly, the lack of findings may have been due in part to 
the fact that the scale itself may have been too generic.  The MHLC scale explores beliefs 
regarding taking care of one’s health generally rather than specific facets of health 
control such as taking medications or attending appointments regularly.   Possibly, a 
more operationally-focused scale would have more accurately captured IHLC in this 
population.   These issues in conjunction with low power may have impacted the 
findings.   
Limitations  
 A major limitation of this study was the extremely small sample size obtained.  
Despite a recruitment period spanning almost 2 years, only 28 participants were 
successfully consented for participation.  Consequently, the statistical power for the 
analyses in this study was very low, limiting both the likelihood that analyses would 
detect significant relationships between variables, as well as interpretation and 
generalizability of the findings.  For example, correlations between posttraumatic stress 
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and provider ratings of adherence were medium in strength, and likely would have been 
significant at the .05 level with an increased sample size.   
 The difficulty in recruitment is itself relevant to the primary research questions of 
this study.  Barriers to recruitment noted by research assistants involved in this study 
included: potential participants not arriving for their clinic appointments, minor children 
present without parents to consent, and individuals refusing to participate.   These 
barriers highlight many challenges and stressors facing this population, and ultimately 
relate to treatment adherence difficulties.  As discussed previously, adolescents with HIV 
face an overwhelming number of  difficulties including: complex self-care regimens; 
interactions with multiple medical providers; disruption of daily activities; enduring 
stigma relating to HIV; developmental delays; and side effects of medication (Brown, 
Lourie, & Pao, 2000; Lewis et al., 1994).  Additionally, many of these adolescents take 
primary responsibility for their medical care.  These stressors along with hardships 
related to ethnic minority status (poverty, low SES, reduced access to medical care, 
distrust in the medical system, limited social and educational resources (Lewis, 2001)) 
may impact trust in the medical system among young people or their caregivers and their 
willingness to participate and afford time for participation in research.   These same 
obstacles may decrease the likelihood that an individual will consistently adhere his/her 
medication and self-care regimen. 
 Problems recruiting ethnic minorities for participation in research are well    
documented (Hinshaw et al., 2004; Rogers, Schwartz, Weitssman & English, 1999; 
Shavers, Lynch, & Burmeister, 2002).  Racial disparities in both health status and 
participation in research among ethnic minorities has become a focus of public health 
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research (Levkoff & Sanchez, 2003).  In particular, African Americans and 
Hispanics/Latinos are among groups federally defined as underrepresented in clinical 
research (Yancy, Ortega, & Kumanyika, 2006) despite being disproportionately affected 
by the AIDS epidemic (Stanford et al., 2003; Stone, Mauch, Steger, Janas, & Craven, 
1997). Therefore, while the small sample size of this study is an important limitation 
impacting the results, it is reflective both of the challenges to treatment adherence in this 
population, and the larger problem surrounding the recruitment and retention of ethnic 
minority participants in research.   
           Another limitation of this study relates to the physiological adherence data 
obtained for this study (viral load, %CD4 counts).  These measures of adherence 
indicated that contrary to research findings of suboptimal adherence in youth with HIV 
(Naar-King et al., 2009; Simoni et al., 2007) this sample was not particularly “sick” or 
non-adherent.  In fact, participants from this study had %CD4 counts mostly in the 
“normal” range, and viral loads suggesting the virus was at least moderately well 
controlled.  More than half the sample had undetectable viral load levels.  The provider 
rating measure also indicated that overall, this group was “moderately adherent”.   
Perhaps a selection bias was operating in that the participants who were able to be present 
to consent for participation were the individuals who regularly attended their medical 
appointments (possibly because they experienced less daily stressors) and experienced 
less difficulty with treatment adherence.  Conversely individuals with treatment 
adherence difficulties and subsequent poorly controlled virus would not have been 
present to consent for participation.   However, clinic data from St. Christopher’s 
Hospital for Children, the sole site of data collection, suggests that the physiological state 
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of this sample was in fact representative of the clinic as a whole.  Demographic data for 
this sample was also consistent with the demographic data from the overall clinic 
population. 
 The immunology clinic at St. Christopher’s Hospital for Children is likely unique 
in that it is consistently ranked highly in city quality rankings for percentage of patients 
with undetectable viral loads and other health outcome measures.  Despite the prevailing 
reports of problems with adherence among youth with HIV, the success of this clinic 
makes it is unlikely that a selection bias was operating in this study.  The relatively 
“healthy” state of this sample, however, may have led to limited findings in that there 
was very little severity in disease status or disparity adherence levels.  Specifically, a 
major limitation is that this data reflect a restriction of range issue, making it less likely 
that any existing correlations between adherence variables and posttraumatic stress levels 
could be identified or statistically demonstrated.  It is also possible that a larger sample 
size would have afforded greater variability in viral load levels and %CD4 counts. 
 Furthermore, other factors may have restricted the outcome and merit of the 
study’s findings.   One feature concerns the type of scales used to measure posttraumatic 
stress symptoms.  While valid and reliable, the PDS and CPSS measures used were self-
report questionnaires, and this appeared to limit the information gleaned from younger 
participants.   Roughly half of the younger participants did not complete the measure at 
all, and several younger participants nominated “benign” events such as an exam at 
school or a poor performance by a favorite professional sport team as traumatic events.  It 
is likely that the use of a structured clinical diagnostic interview would have yielded more 
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substantive information regarding trauma histories and current symptoms of 
posttraumatic stress for these individuals.  
 Another related issue concerns the lack of measures specifically normed on 
minority populations.  The lack of normative data regarding African American, Hispanic 
and low income individuals may have limited the value of the measures used by 
neglecting ethnic and cultural factors and thereby underestimating psychopathology 
(Okazaki & Sue, 1995).   Another factor associated with measurement in this study was 
the inability to accurately measure rates of PTSD in this sample.  While it was still 
possible to measure posttraumatic stress symptoms, identifying exact numbers of 
participants who met criteria for a diagnosis may have helped to further elucidate the 
relationship between posttraumatic stress and adherence. 
Clinical Implications and Future Research Directions 
 The pediatric literature has long recognized the clinical significance of 
posttraumatic stress symptoms on health outcomes even without a diagnosis of PTSD.  
The model of Pediatric Medical Traumatic Stress put forth by Kazak and colleagues 
(2006) is based largely on the understanding that traumatic stress responses experienced 
by youth and their families may cause significant psychological distress and disruption of 
functioning even when a diagnosis of PTSD is not met.  The model focuses on the 
subjective experiences and beliefs of the child and family in their ongoing and evolving 
traumatic stress responses   Intervention approaches based on the model focus on 
identifying adaptive beliefs about adversities and reframing maladaptive ones, thereby 
lessening or preventing post traumatic stress symptoms.  Ongoing unchecked 
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posttraumatic stress responses may otherwise negatively affect health outcomes by 
impeding treatment adherence and other health behaviors.  
 Consistent with this model, findings of this study point to the necessity of treating 
posttraumatic stress symptoms in order to allow individuals to take better care of their 
health. There is a dearth of research assessing clinical interventions for the promotion or 
improvement of treatment adherence among youth with HIV and less still that targets 
psychosocial difficulties specifically (Reisner, Mimiaga, Skeer, et al., 2009).  In their 
review of studies investigating adherence and adherence-related interventions in youth 
with HIV, Reisner, Mimiaga, Skeer and colleagues (2009) found 7 published studies 
targeting improved adherence to antiretroviral medications in HIV-infected youth.  
Remarkably, none of the studies directly addressed psychosocial difficulties experienced 
by participants in order to improve adherence.   This is especially surprising given that 
psychosocial factors are consistently linked to treatment adherence difficulties (Murphy 
et al., 2000; Reisner, Mimiaga, Skeer, et al., 2009; Williams et al., 2006).  Furthermore, 
interventions geared towards adults with HIV have begun to utilize treatments for 
psychosocial difficulties such as depression and anxiety in order to improve medication 
adherence with some success (Safren et al., 2004).  The lack of a psychosocial focus in 
treatment interventions geared towards youth with HIV represents a crucial gap in the 
adherence intervention research.  Taken together with previous research, findings from 
this study highlight the importance of incorporating trauma-focused psychosocial 
interventions geared towards addressing the traumatic nature of being diagnosed and 
living with HIV, as well as exposure to other life events.  These interventions will 
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undoubtedly positively impact adherence to medication and other self-care regimens 
relating to HIV.   
  Adult research suggests that multicomponent strategies tend to be the most 
effective in improving poor adherence (Reisner, Mimiaga, Safren, et al., 2009).  For 
example, Ellis and colleagues (2006) devised a promising promising multisystemic 
intervention rooted in social-ecological theory, which they piloted on 18 pediatric 
(perinatally-infected) HIV patients (ages 20 months to 16 years).  The accessible, home-
based, family-centered intervention was designed to target barriers to adherence within 
the multiple systems a child operates (child, family, and community).  Treatment 
included cognitive behavioral therapy interventions to address psychosocial issues 
identified.  Community level barriers such as barriers to keeping appointments, troubled 
relationships with medical care providers and other social service agencies were 
addressed through targeted interventions as well.  Outcomes of the program demonstrated 
clinically and statistically meaningful changes in viral load levels (collected 
retrospectively) which were sustained 3 months post-treatment.   Therefore, future 
trauma-focused interventions will likely be most effective as part of a multimodal 
intervention package addressing the multiple barriers to treatment adherence for youth 
both perinatally and behaviorally-infected with HIV.    
  Future research should also focus on exploring the applicability of the HBM to 
adolescents with HIV and elucidating the role of IHLC specifically by incorporating 
more treatment and disease-specific assessments of health beliefs.   
 With regard to treatment adherence, this study attempted to explore different 
facets of adherence by using objective and subjective measures of adherence.  Findings 
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highlight the need to further explore the value of certain existing methods of assessing 
treatment adherence.  For example, since it appears a selection bias was not operating in 
this study, it can be deduced that patients with poor clinic attendance may not differ along 
physiological or objective measures of adherence from those patients who do keep 
appointments.  The utility of appointment attendance as an adherence measure then 
becomes questionable.   Additionally, although it was not feasible to utilize self-report 
measures in this study, these tools comprise one of the most practical and widely used 
measures of adherence and if used may have further developed interpretations regarding 
the adherence data (Simoni et al., 2007).   Other available adherence measures such as 
pill counts or MEMS bottle caps may also have provided more useful information.  More 
research investigating the validity and reliability of these measures is needed.  In 
summary, results confirm that much work remains to be done towards establishing a 
standardized, reliable, valid and cost-effective method of measuring treatment adherence.  
Unfortunately, until a standard method of assessing adherence is created, it will continue 
to be impossible to accurately describe adherence difficulties in this population and to 
adequately address the adherence problem. 
 Finally, clinical interventions geared towards improving treatment adherence will 
only succeed if barriers to the successful recruitment and retention of minority 
participants are overcome.  It will be necessary for these interventions to take a culturally 
competent approach to addressing the unique needs of this population.  As most studies 
investigating youth with HIV suffer from small sample sizes, multi-site studies may be 
required and may also assist in better capturing a broader range of adherence-related data.  
Home-based data collection may also help improve participation by making studies more 
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convenient and accessible for families facing numerous stressors.  Lastly, the majority of 
the participants in this study reported positive appraisals regarding their participation in 
this study, and the majority indicated feeling trust in the information they obtained about 
informed consent.  It is possible that if satisfaction ratings regarding research 
participation become better publicized, individuals will be more likely to consent to 
participation in research studies.   
Conclusions 
 Findings from this study suggest that adolescents and young adults behaviorally 
and perinatally-infected with HIV experience symptoms of posttraumatic stress related to 
the diagnosis of HIV itself as well as other traumatic life events.  Findings further suggest 
that these symptoms may be related to problems with treatment adherence.  These results 
underscore the need to devise clinical interventions aimed at addressing psychosocial 
difficulties experienced by youth with HIV order to improve treatment adherence.  This 
study uncovered problems in recruitment which likely relate to the multitude of stressors 
experienced by individuals with HIV as well as the general issue of increasing 
participation in research among ethnic minorities.   Findings also supported the need to 
devise a standardized and valid method of assessing treatment adherence. Mitigating 
psychological distress and maximizing treatment adherence among youth with HIV will 
have a far-reaching impact on public-health. 
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Table 1. 
Preliminary Analyses for Transmission Group Equality on Relevant Demographic Variables 
 
            Variable                                    X 2           df         t        p 
                               Combined             Perinatal          Behavioral 
 
N        28       13       15     
 
Age: M (SD) 
         Range 
 
17.14 (3.05) 
12-22 
 
14.54 (2.22) 
12-18 
 
19.4 (1.40) 
17-22 
  
 
19.7 
 
 
-6.8 
 
 
.000*** 
 
Gender 
         Male     % (#) 
         Female  % (#) 
        
 
 
53.6 (15) 
46.4 (13) 
 
 
53.8 (7) 
46.2 (6) 
 
 
 
53.3 (8) 
46.7 (7) 
 
 
.00 
 
 
1 
  
 
1.000 
Ethnicity 
        African American % (#) 
        Latino % (#) 
        Caucasian % (#) 
        Other % (#) 
         
 
60.7  (17) 
17.9  (5) 
14.3  (4) 
7.2    (2) 
 
38.5  (5) 
30.8  (4) 
23.1  (3) 
7.7    (1) 
 
80.0 (12) 
6.7   (1) 
6.7   (1) 
6.7   (1) 
 
1.5 
 
1+ 
  
.311 
Medication 
        On Meds % (#)          
 
 
75     (21) 
 
84.6  (11) 
 
66.7 (10) 
 
.43 
   
.512 
 
*p <.100, ** p<.050, ***p<.010 
 
+ Chi Square for ethnicity done comparing Caucasians versus non-Caucasians.  
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Table 2. 
 
Adherence-Related Variables 
 
 
Variable         M         SD  Range           df        t           p 
 
 
 
%CD4 Count 
   Perinatal 
   Behavioral 
   Combined 
 
 
30.44 
28.12 
29.19 
 
 
9.15 
9.12 
9.02 
 
 
14.25-40.30 
15.00-45.50 
14.25-45.50 
 
 24 
 
0.64 
 
0.53 
 
Log Viral 
Load 
   Perinatal 
   Behavioral 
   Combined 
 
 
 
1.26 
1.80 
1.54 
 
 
 
1.65 
1.64 
1.63 
 
 
 
0.00-4.43 
0.00-4.29 
0.00-4.43 
 
 26 
 
-0.86 
 
0.40 
 
Provider 
Rating 
   Perinatal 
   Behavioral 
   Combined 
 
 
 
5.54 
4.53 
5.00 
 
 
 
1.33 
1.60 
1.54 
 
 
 
3.00-7.00 
2.00-7.00 
2.00-7.00 
 
 26 
 
1.80 
 
.085* 
*p < .100, ** p < .050, ***p < .010 
94 
 
Table 3. 
Means and Standard Deviations on Psychological Variables 
       Sample Specific       Normative Data 
Variable      M   SD       M         SD       
 
 
Average Total Symptom Severity  
 (all participants) 
Non HIV-Related Trauma a 
HIV-Related Trauma b 
 
 
 
0.81 
1.14 
 
 
 
0.67 
0.84 
  
Posttraumatic Stress Diagnostic Scale (Non-
HIV)c 
PDS: Average Total Symptom Severity 
PDS: Average Reexperiencing  
PDS: Average Avoidance 
PDS: Average Arousal 
 
 
 
0.87 
0.79 
0.93 
0.87 
 
 
 
0.70 
0.67 
0.80 
0.77 
 
 
1.38 
1.85 
1.32 
1.11 
 
 
0.86 
0.82 
0.95 
1.00 
Posttraumatic Stress Diagnostic Scale (HIV)c 
PDS: Average Total Symptom Severity 
PDS: Average Reexperiencing  
PDS: Average Avoidance 
PDS: Average Arousal  
 
 
1.17 
1.13 
1.35 
0.99 
 
0.92 
0.97 
0.96 
0.98 
 
 
1.38 
1.85 
1.32 
1.11 
 
0.86 
0.82 
0.95 
1.00 
Child PTSD Symptom Scale (Non-HIV)d 
CPSS: Average Total Symptom Severity 
CPSS: Average Reexperiencing 
CPSS: Average Avoidance 
CPSS: Average Arousal 
 
 
0.67 
0.93 
0.50 
0.63 
 
0.64 
1.09 
0.41 
0.80 
 
0.45 
0.38 
0.39 
0.54 
 
0.48 
0.54 
0.49 
0.54 
Child PTSD Symptom Scale (HIV)e 
CPSS: Average Total Symptom Severity 
CPSS: Average Reexperiencing 
CPSS: Average Avoidance 
CPSS: Average Arousal 
 
1.07 
1.43 
0.69 
1.07 
 
0.66 
1.08 
0.61 
0.85 
 
0.45 
0.38 
0.39 
0.54 
 
0.48 
0.54 
0.49 
0.54 
 
Health Locus of Controlf 
HLC: Internal 
 
 
26.54 
 
 
5.23 
 
 
25.10 
 
 
4.89  
 
an = 21,  bn = 22, cn = 15, dn = 6, en = 6, fn = 28 
Note. Normative data for PDS data published in Foa et al., 1997.  Normative data for CPSS 
published in Foa et al., 2001.  Normative data for HLC published in Wallston et al., 1978
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Table 4. 
 
Correlations between Adherence Variables, PTSD Symptom Severity, &  
 
Internal Health Locus of Control 
 
 
Variable    Non-HIV Trauma       HIV-Related Trauma     Internal Health 
     Symptom  Severity     Symptom Severity       Locus of Control 
                              r                 p         r                 p                 r               p 
    
 
%CD4  
 
   0.20 
 
   0.375 
 
    -0.06 
 
    0.790 
 
  -0.15 
 
  0.475 
 
Log Viral 
Load 
 
   0.38+ 
 
   0.099* 
 
     0.26+ 
 
    0.266 
 
   0.03 
 
  0.896 
 
Provider 
Rating of 
Adherence 
      
   -0.48++ 
 
 0.038** 
 
    -0.43++ 
                         
    0.060* 
 
   0.16 
 
  0.420 
 
Internal 
Health 
Locus of 
Control 
 
    -0.14 
 
 0.560 
 
    -0.15 
 
    0.519 
 
    
 
*p <.100, ** p<.050, ***p<.010 
 
+Analysis controlled for developmental level 
 
++Analysis controlled for developmental level and gender
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Table 5. 
 
Partial Correlations Controlling for Internal Health Locus of Control 
 
 
    Variable        Non-HIV Trauma Symptom        HIV-Related Trauma Symptom 
           Severity               Severity 
                r                       p                       r                       p 
     
% CD4       0.19      0.427      -0.09 
 
     0.724 
Log Viral Load 
 
      0.38+      0.106       0.26+      0.274 
Provider Rating 
Of Adherence 
     -0.47++      0.047**      -0.42++      0.074* 
*p <.100, ** p<.050, ***p<.010 
 
+Analysis controlled for developmental level 
 
++Analysis controlled for developmental level and gender 
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APPENDIX A. MEASURES 
 
 
 
 
 
           MHLC-A: Multidimensional Health Locus of Control Scales-Form A 
 
          Circle the number that best describes your disagreement/agreement with the following          
          statements. 
 
  Strongly 
Disagree 
    Strongly 
Agree 
        
1. If I get sick, it is my own behavior 
which determines how soon I get 
well again. 
 
1 2 3 4 5 6 
2. No matter what I do, if I am going to 
get sick, I will get sick. 
 
1 2 3 4 5 6 
3. Having regular contact with my 
physician is the best way for me to 
avoid illness. 
 
1 2 3 4 5 6 
4. Most things that affect my health 
happen to me by accident. 
 
1 2 3 4 5 6 
5. Whenever I don’t feel well, I should 
consult a medically trained 
professional. 
 
1 2 3 4 5 6 
6. I am in control of my health. 
 
1 2 3 4 5 6 
7. My family has a lot to do with my 
becoming sick or staying healthy. 
 
1 2 3 4 5 6 
8. When I get sick I am to blame. 
 
1 2 3 4 5 6 
9. Luck plays a big part in determining 
how soon I will recover from an 
illness. 
 
1 2 3 4 5 6 
10. Health professionals control my 
health. 
 
1 2 3 4 5 6 
11. My good health is largely a matter of 
good fortune. 
 
1 2 3 4 5 6 
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12. 
 
The main thing which affects my 
health is what I myself do. 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
        
13. If I take care of myself, I can avoid 
illness. 
 
1 2 3 4 5 6 
14. When I recover from an illness, it’s 
usually because other people (for 
example, doctors, nurses, family, 
friends) have been taking good care 
of me. 
 
1 2 3 4 5 6 
15. No matter what I do, I’m likely to 
get sick. 
 
1 2 3 4 5 6 
16. If it’s meant to be, I will stay 
healthy. 
 
1 2 3 4 5 6 
17. If I take the right actions, I can stay 
healthy. 
 
1 2 3 4 5 6 
18. Regarding my health, I can only do 
what my doctor tells me to do. 
 
1 2 3 4 5 6 
 
(IHLC)   1,6,8,12,13,17    (PHLC)   3,5,7,10,14,18    (CHLC)   2,4,9,11,15,16 
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PDS Scale 
Part I 
 
On the lines below, briefly describe the traumatic event that bothers you the most. 
 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
________________________________________________________________________ 
________________________________________________________________________ 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
 
 
Below are several questions about the traumatic event you just described above. 
 
1. How long ago did the traumatic event happen? 
 (Circle ONE) 
1. Less than 1 month 
2. 1 to 3 months 
3. 3 to 6 months 
4. 6 months to 3 years 
5. 3 to 5 years 
6. More than 5 years 
 
For the following questions, circle Y for Yes or N for No. 
 
During this traumatic event: 
2. Y  N  Were you physically injured? 
3. Y  N  Was someone else physically injured? 
4. Y  N  Did you think that your life was in danger? 
5. Y  N  Did you think that someone else’s life was in danger? 
6. Y  N  Did you feel helpless? 
7. Y  N  Did you feel terrified? 
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Part 2 
 
Below is a list of problems that people sometimes have after experiencing a traumatic event.  
Read each one carefully and circle the number (0-3) that best describes how often that 
problem has bothered you IN THE PAST MONTH.  Rate each problem with respect to the 
traumatic event you described in Item 14.  
  
0 Not at all or only one time 
1 Once a week or less/ once in a while 
2 2 to 4 times a week/ half the time 
3 5 or more times a week/ almost always 
 
8.  0 1 2 3  Having upsetting thoughts or images about the traumatic event that came into  
       your head when you didn’t want them to 
 
9.  0 1 2 3  Having bad dreams or nightmares about the traumatic event 
 
10. 0 1 2 3 Reliving the traumatic event, acting or feeling as if it was happening again 
 
11 .0 1 2 3  Feeling emotionally upset when you were reminded of the traumatic event  
       (for example, feeling scared, angry, sad, guilty, etc.)  
 
12. 0 1 2 3  Experiencing physical reactions when you were reminded of the traumatic  
       event (for example, breaking out in a sweat, heart beating fast) 
 
13. 0 1 2 3  Trying not to think about, talk about, or have feelings about the traumatic  
       Event 
 
14. 0 1 2 3  Trying to avoid activities, people, or places that remind you of the traumatic  
       Event 
 
15. 0 1 2 3  Having much less interest or participating much less often in important  
       activities 
 
16. 0 1 2 3  Feeling distant or cut off from people around you 
 
17. 0 1 2 3  Feeling emotionally numb (for example, being unable to cry or unable to  
       have loving feelings) 
 
18. 0 1 2 3  Feeling as if your future plans or hopes will not come true (for example, you  
       will not have a career, marriage, children, or a long life) 
 
19. 0 1 2 3  Having trouble falling or staying asleep 
 
20. 0 1 2 3  Feeling irritable or having fits of anger
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21. 0 1 2 3  Having trouble concentrating (for example, drifting in and out of  
       conversations, losing track of a story on television, forgetting what you read) 
 
22. 0 1 2 3  Being overly alert (for example, checking to see who is around you, being  
       uncomfortable with your back to a door, etc.) 
 
23. 0 1 2 3  Being jumpy or easily startled (for example, when someone walks up behind  
       you) 
 
 
 
24.  How long have you experienced the problems that you reported above? 
       (Circle ONE) 
 
1 Less than one month 
2 1 to 3 months 
3 More than 3 months 
 
25.  How long after the traumatic event did these problems begin? 
       (Circle ONE) 
 
1 Less than 6 months 
2 6 or more months 
 
Part 3 
 
Indicate below if the problems you rated in Part 3 have interfered with any of the 
following areas of your life DURING THE PAST MONTH.  Circle Y for Yes, N for No. 
 
26.  Y  N  Work 
27.  Y  N  Household chores and duties 
28.  Y  N  Relationships with friends 
29.  Y  N  Fun and leisure activities 
30.  Y  N  Schoolwork 
31.  Y  N  Relationships with your family 
32.  Y  N  Sex life 
33.  Y  N  General satisfaction with life 
34.  Y  N  Overall level of functioning in all areas of your life 
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PDS Scale 
Part I 
 
On the lines below, briefly describe learning about your HIV diagnosis, or something 
else about having HIV which bothers you the most  
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
 
 
 
Below are several questions about the traumatic event you just described above. 
 
 
 
 
1.  How long ago did the traumatic event happen? 
 (Circle ONE) 
7. Less than 1 month 
8. 1 to 3 months 
9. 3 to 6 months 
10. 6 months to 3 years 
11. 3 to 5 years 
12. More than 5 years 
 
For the following questions, circle Y for Yes or N for No. 
 
During this traumatic event: 
2.  Y  N  Were you physically injured? 
3.  Y  N  Was someone else physically injured? 
4.  Y  N  Did you think that your life was in danger? 
5.  Y  N  Did you think that someone else’s life was in danger? 
6.  Y  N  Did you feel helpless? 
7.  Y  N  Did you feel terrified? 
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Part 2 
 
Below is a list of problems that people sometimes have after experiencing a traumatic 
event.  Read each one carefully and circle the number (0-3) that best describes how often 
that problem has bothered you IN THE PAST MONTH.  Rate each problem with respect 
to the traumatic event you described in Item 14.  
  
4 Not at all or only one time 
5 Once a week or less/ once in a while 
6 2 to 4 times a week/ half the time 
7 5 or more times a week/ almost always 
 
8.   0 1 2 3  Having upsetting thoughts or images about the traumatic event that came into  
       your head when you didn’t want them to 
 
9.   0 1 2 3  Having bad dreams or nightmares about the traumatic event 
 
10. 0 1 2 3  Reliving the traumatic event, acting or feeling as if it was happening again 
 
11. 0 1 2 3  Feeling emotionally upset when you were reminded of the traumatic event  
       (for example, feeling scared, angry, sad, guilty, etc.)  
 
12. 0 1 2 3  Experiencing physical reactions when you were reminded of the traumatic  
       event (for example, breaking out in a sweat, heart beating fast) 
 
13. 0 1 2 3  Trying not to think about, talk about, or have feelings about the traumatic  
       Event 
 
14. 0 1 2 3  Trying to avoid activities, people, or places that remind you of the traumatic  
       Event 
 
15. 0 1 2 3  Having much less interest or participating much less often in important  
       activities 
 
16. 0 1 2 3  Feeling distant or cut off from people around you 
 
17. 0 1 2 3  Feeling emotionally numb (for example, being unable to cry or unable to  
       have loving feelings) 
 
18. 0 1 2 3  Feeling as if your future plans or hopes will not come true (for example, you  
       will not have a career, marriage, children, or a long life) 
 
19. 0 1 2 3  Having trouble falling or staying asleep 
 
20. 0 1 2 3  Feeling irritable or having fits of anger
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21. 0 1 2 3  Having trouble concentrating (for example, drifting in and out of  
       conversations, losing track of a story on television, forgetting what you read) 
 
22. 0 1 2 3  Being overly alert (for example, checking to see who is around you, being  
       uncomfortable with your back to a door, etc.) 
 
23. 0 1 2 3  Being jumpy or easily startled (for example, when someone walks up behind  
       you) 
 
 
24.  How long have you experienced the problems that you reported above? 
       (Circle ONE) 
 
4 Less than one month 
5 1 to 3 months 
6 More than 3 months 
 
25.  How long after the traumatic event did these problems begin? 
       (Circle ONE) 
 
3 Less than 6 months 
4 6 or more months 
 
Part 3 
 
Indicate below if the problems you rated in Part 3 have interfered with any of the 
following areas of your life DURING THE PAST MONTH.  Circle Y for Yes, N for No. 
 
26.  Y  N  Work 
27.  Y  N  Household chores and duties 
28.  Y  N  Relationships with friends 
29.  Y  N  Fun and leisure activities 
30.  Y  N  Schoolwork 
31.  Y  N  Relationships with your family 
32.  Y  N  Sex life 
33.  Y  N  General satisfaction with life 
34.  Y  N  Overall level of functioning in all areas of your life 
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Child PTSD Symptom Scale (CPSS) 
 
Part 1 
 
Below is a list of problems that kids sometimes have after experiencing an upsetting 
event.  Read each one carefully and circle the number (0-3) that best describes how 
often that problem has bothered you IN THE LAST 2 WEEKS. 
 
Please write down your most distressing event: 
 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
_____________________________________________________________________ 
 
Length of time since the event: 
______________________________________________________________________ 
 
0 1 2 3 
Not at all or only at 
one time 
Once a week or 
less/ once in a 
while 
2 to 4 times a week/ 
half the time 
5 or more times 
a week/almost 
always 
 
1. 0 1 2 3 Having upsetting thoughts or images about the 
event that came into your head when you didn’t 
want them to 
2. 0 1 2 3 Having bad dreams or nightmares 
3. 0 1 2 3 Acting or feeling as if the event was happening 
again (hearing something or seeing a picture 
about it and feeling as if I am there again) 
4. 0 1 2 3 Feeling upset when you think about it or hear 
about the event (for example, feeling scared, 
angry, sad, guilty, etc) 
5. 0 1 2 3 Having feelings in your body when you think 
about or hear about the event (for example, 
breaking out into a sweat, heart beating fast) 
6. 0 1 2 3 Trying not to think about, talk about, or have 
feelings about the event 
7. 0 1 2 3 Trying to avoid activities, people, or places that 
remind you of the traumatic event 
8. 0 1 2 3 Not being able to remember an important part 
of the upsetting event 
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9. 0 1 2 3 Having much less interest or doing things you 
used to do 
10. 0 1 2 3 Not feeling close to people around you 
11. 0 1 2 3 Not being able to have strong feelings (for 
example, being unable to cry or unable to feel 
happy) 
12. 0 1 2 3 Feeling as if your future plans or hopes will not 
come true (for example, you will not have a job 
or getting married or having kids) 
 
0 1 2 3 
Not at all or only at 
one time 
Once a week or 
less/ once in a 
while 
2 to 4 times a 
week/ half the 
time 
5 or more times a 
week/almost always 
 
 
13. 0 1 2 3 Having trouble falling or staying asleep 
14. 0 1 2 3 Feeling irritable or having fits of anger 
15. 0 1 2 3 Having trouble concentrating (for example, 
losing track of a story on the television, 
forgetting what you read, not paying attention in 
class) 
16. 0 1 2 3 Being overly careful (for example, checking to 
see who is around you and what is around you) 
17. 0 1 2 3 Being jumpy or easily startled (for example, 
when someone walks up behind you) 
 
Part 2 
 
Indicate below if the problems you rated in Part 1 have gotten in the way with any of the 
following areas of your life DURING THE PAST 2 WEEKS. 
 
 Yes No  
18. Y N Doing your prayers 
19. Y N Chores and duties at home 
20. Y N Relationships with friends 
21. Y N Fun and hobby activities 
22. Y N Schoolwork 
23. Y N Relationships with your family 
24. Y N 
General happiness with your life 
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Child PTSD Symptom Scale (CPSS) 
 
Part 1 
 
Below is a list of problems that kids sometimes have after experiencing an upsetting 
event.  Read each one carefully and circle the number (0-3) that best describes how 
often that problem has bothered you IN THE LAST 2 WEEKS. 
 
Please write down an upsetting event related to having HIV (such as receiving the 
diagnosis, learning about your diagnosis, being hospitalized, etc.): 
 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
______________________________________________________________________ 
 
Length of time since the event: 
______________________________________________________________________ 
 
0 1 2 3 
Not at all or 
only at one time 
Once a week 
or less/ once 
in a while 
2 to 4 times a 
week/ half the 
time 
5 or more times a 
week/almost always 
 
1. 0 1 2 3 Having upsetting thoughts or images about 
the event that came into your head when you 
didn’t want them to 
2. 0 1 2 3 Having bad dreams or nightmares 
3. 0 1 2 3 Acting or feeling as if the event was 
happening again (hearing something or 
seeing a picture about it and feeling as if I am 
there again) 
4. 0 1 2 3 Feeling upset when you think about it or hear 
about the event (for example, feeling scared, 
angry, sad, guilty, etc) 
5. 0 1 2 3 Having feelings in your body when you think 
about or hear about the event (for example, 
breaking out into a sweat, heart beating fast) 
6. 0 1 2 3 Trying not to think about, talk about, or have 
feelings about the event 
7. 0 1 2 3 Trying to avoid activities, people, or places 
that remind you of the traumatic event 
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8. 0 1 2 3 Not being able to remember an important part 
of the upsetting event 
9. 0 1 2 3 Having much less interest or doing things you 
used to do 
10. 0 1 2 3 Not feeling close to people around you 
11. 0 1 2 3 Not being able to have strong feelings (for 
example, being unable to cry or unable to feel 
happy) 
12. 0 1 2 3 Feeling as if your future plans or hopes will 
not come true (for example, you will not have 
a job or getting married or having kids) 
 
0 1 2 3 
Not at all or only 
at one time 
Once a week or 
less/ once in a 
while 
2 to 4 times a week/ 
half the time 
5 or more times 
a week/almost 
always 
 
 
13. 0 1 2 3 Having trouble falling or staying asleep 
14. 0 1 2 3 Feeling irritable or having fits of anger 
15. 0 1 2 3 Having trouble concentrating (for example, 
losing track of a story on the television, 
forgetting what you read, not paying attention 
in class) 
16. 0 1 2 3 Being overly careful (for example, checking to 
see who is around you and what is around 
you) 
17. 0 1 2 3 Being jumpy or easily startled (for example, 
when someone walks up behind you) 
 
Part 2 
 
Indicate below if the problems you rated in Part 1 have gotten in the way with any of the 
following areas of your life DURING THE PAST 2 WEEKS. 
 
18. Y N Doing your prayers 
19. Y N Chores and duties at home 
20. Y N Relationships with friends 
21. Y N Fun and hobby activities 
22. Y N Schoolwork 
23. Y N Relationships with your family 
24. Y N 
General happiness with your life 
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THE LIFE EXPERIENCES SURVEY 
 
Listed below are a number of events that sometimes bring about change in the lives of those who experience them and which 
necessitate social readjustment.  Please check those events that you have experienced in the recent past and indicate the time during 
which you have experienced each event.  Be sure that all check marks are directly across from the items they correspond to. 
 
Also, for each item checked below, please indicate the extent to which you viewed the event as having either a positive or negative 
impact on your life at the time the event occurred.  That is, indicate the type and extent of impact that the event had.  A rating of -3 
would indicate an extremely negative impact.  A rating of 0 suggests no impact either positive or negative. A rating of +3 would 
indicate an extremely positive impact. 
 
 0 to 6 mo. 7 mo. to 1 
year 
More 
than 1 
year 
Extremely 
 negative 
Moderately 
negative 
Somewhat 
negative 
No 
impact 
Slightly 
positive 
Moderately 
positive 
Extremely 
Positive 
1.Marriage ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
2. Detention in jail, or 
comparable institution 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
3. Death of a spouse ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
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 0 to 6 mo. 7 mo. to 1 
year 
More 
than 1 
year 
Extremely 
 negative 
Moderately 
negative 
Somewhat 
negative 
No 
impact 
Slightly 
positive 
Moderately 
positive 
Extremely 
Positive 
4. Major change in 
sleeping habits (much 
more or much less sleep) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
5. Death of close family 
member: 
a. Father 
b. Mother 
c. Sister 
d. Brother 
e. Grandfather 
f. Grandmother 
g. Spouse 
h. Other (specify) 
 
 
 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
 
 
 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
 
 
 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
 
 
 
-3 
-3 
-3 
-3 
-3 
-3 
-3 
-3 
 
 
-2 
-2 
-2 
-2 
-2 
-2 
-2 
-2 
 
 
-1 
-1 
-1 
-1 
-1 
-1 
-1 
-1 
 
 
0 
0 
0 
0 
0 
0 
0 
0 
 
 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
 
 
+2 
+2 
+2 
+2 
+2 
+2 
+2 
+2 
 
 
+3 
+3 
+3 
+3 
+3 
+3 
+3 
+3 
6. Major change in eating 
habits (much more or 
much less food intake) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
7. Foreclosure on 
mortgage or loan 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
8. Death of close friend ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
9. Outstanding personal 
achievement 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
10. Minor law violations 
(traffic tickets, disturbing 
the peace, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
11. Male: Wife/girlfriend 
pregnancy 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
12.  Female: pregnancy ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
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 0 to 6 mo. 7 mo. to 1 
year 
More 
than 1 
year 
Extremely 
 negative 
Moderately 
negative 
Somewhat 
negative 
No 
impact 
Slightly 
positive 
Moderately 
positive 
Extremely 
positive 
13. Changed work 
situation (different work 
responsibility, major 
change in working  
 conditions, working 
hours, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
14. New job ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
15. Serious illness or 
injury of close family 
member:  
a. Father 
b. Mother 
c. Sister 
d. Brother 
e. Grandfather 
f. Grandmother 
g. Spouse 
h. Other (specify) 
 
 
 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
 
 
 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
 
 
 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
∍ 
 
 
 
-3 
-3 
-3 
-3 
-3 
-3 
-3 
-3 
 
 
-2 
-2 
-2 
-2 
-2 
-2 
-2 
-2 
 
 
-1 
-1 
-1 
-1 
-1 
-1 
-1 
-1 
 
 
0 
0 
0 
0 
0 
0 
0 
0 
 
 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
+1 
 
 
+2 
+2 
+2 
+2 
+2 
+2 
+2 
+2 
 
 
+3 
+3 
+3 
+3 
+3 
+3 
+3 
+3 
16. Sexual difficulties ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
17. Trouble with 
employer (in danger of 
losing job, being 
suspended, demoted, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
18. Trouble with in-laws ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
19. Major change in 
financial status (a lot 
better off or a lot worse 
off) 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
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 0 to 6 mo. 7 mo. to 1 
year 
More 
than 1 
year 
Extremely 
 negative 
Moderately 
negative 
Somewhat 
negative 
No 
impact 
Slightly 
positive 
Moderately 
positive 
Extremely 
positive 
20. Major change in 
closeness of family 
members (increased or 
decreased closeness) 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
21. Gaining a new family 
member (through birth, 
adoption, family member 
moving in, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
22. Change of residence ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
23. Marital separation 
from mate (due to 
conflict) 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
24. Major change in 
church activities 
(increased or decreased 
attendance) 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
25. Marital reconciliation 
with mate 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
26. Major change in 
number or arguments 
with spouse (a lot more or 
a lot less arguments) 
 
   ∍     ∍     ∍ -3 -2 -1 0 +1 +2 +3 
27. Married male: change 
in wife’s work outside the 
home (beginning work, 
ceasing work, changing to 
a new job, etc) 
 
   ∍     ∍     ∍ -3 -2 -1 0 +1 +2 
 
 
 
+3 
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0 to 6 mo. 7 mo. to 1 
year 
More 
than 1 
year 
Extremely 
 negative 
Moderately 
negative 
Somewhat 
negative 
No 
impact 
Slightly 
positive 
Moderately 
positive 
Extremely 
positive 
28. Married female:  
change in husband’s work 
(loss of job, beginning 
new job,retirement, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
29. Major change in usual 
type and/or amount of 
recreation 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
30. Borrowing more than 
$10,000 (buying 
       home, business, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
31. Borrowing less than 
$10,000 (buying car, TV, 
getting school loan, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
32. Being fired from job ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
33. Male: Wife/girlfriend 
having abortion 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
34. Female: Having 
abortion 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
35. Major personal illness 
or injury 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
36. Major change in 
social activities, e.g., 
parties, movies, visiting 
(increased or decreased 
participation) 
 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
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0 to 6 mo. 7 mo. to 1 
year 
More 
than 1 
year 
Extremely 
 negative 
Moderately 
negative 
Somewhat 
negative 
No 
impact 
Slightly 
positive 
Moderately 
positive 
Extremely 
positive 
37. Major change in 
living conditions of 
family (building new 
home, remodeling, 
deterioration of home 
neighborhood, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
38. Divorce ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
39. Serious injury or 
illness of close friend 
∍ ∍ ∍ -3 -2 -1 0s +1 +2 +3 
40. Retirement from work ∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
41. Son or daughter 
leaving home (due to 
marriage, college, etc) 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
42. Ending of formal 
schooling 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
43. Separation from 
spouse (due to work, 
travel, etc) 
 
∍ ∍ 
 
∍ -3 -2 -1 0 +1 +2 +3 
44. Engagement 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
45. Breaking up with 
boyfriend/girlfriend 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
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 0 to 6 mo. 7 mo. to 1 
year 
> 1 year Extremely 
negative 
Moderately 
negative 
Somewhat 
negative 
No 
impact 
Slightly 
positive 
Moderately 
positive 
Extremel
y 
positive 
46. Leaving home for the 
first time 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
47. Reconciliation with  
       boyfriend/girlfriend 
 
∍ ∍ 
∍ 
-3 -2 -1 0 +1 +2 +3 
49. Separation from 
caregiver(s) 
          
50. Been treated 
differently because of 
HIV 
  
 
       
 
Other recent experiences 
that have had an impact 
on your life. List and 
rate: 
  
 
       
51. 
____________________
_____________ 
∍ ∍ 
∍ 
-3 -2 -1 0 +1 +2 +3 
52. 
____________________ 
 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
53. 
____________________
_____________ 
∍ ∍ ∍ -3 -2 -1 0 +1 +2 +3 
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#______ 
RRPQ-C 
 
We want to know your opinions about what it was like for you to be in this study.  Your 
answers will help us understand how people feel about being in studies like this one.  We 
REALLY want to hear your opinions, even if there were things you did not like.  For each 
item below, please circle the number under the answer that is true for you.  There are no 
right or wrong answers. 
 
 
         NO Maybe (in  Yes 
        the middle) 
_____________________________________________________________________________________ 
1.  Being in this study was boring   1                  3                5 
  
2.  I am glad that I was in this study   1                  3                5  
 
3.  It was my choice if I was in the study  1                  3                5  
    (I could have said no even if other people wanted 
     me to say yes.) 
 
4.  Being in this study make me feel upset or sad. 1                  3                5  
 
5.  The things I said will stay private (no one else  1                  3                5  
     will know I said them). 
 
6.  I am sorry I was in this study.   1                  3                5  
 
7.  Being in this study made me feel good about  1                  3                5  
      myself. 
 
8.  I was told the truth about the study before it    1                  3                5  
     started. 
 
9.  I feel good about helping other people by being  1                  3                5  
     in this study. 
 
10. I knew I could skip questions or parts of the  1                  3                5  
      study if I wanted to. 
 
11. I knew I could stop at any time.   1                  3                5  
 
12. I knew I could ask to take a break whenever 1                  3                5  
      I wanted. 
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Clinical Provider Rating Scale 
 
This is to be completed by the clinic team. 
 
Date:  ______________________________ 
 
Surveying Nurse: _____________________________ 
 
 
In the past six months, how would you rate the individual’s participation in their HIV 
care on the following categories: 
 
Appropriate follow through with recommended medication regimen 
Completes all required lab tests 
Follows through with appointments outside of this clinic 
Completes scheduled home visits 
 
For a participant to be considered “successful” in any of the above categories, they must 
have that category as part of their care plan (ex: if someone does not ever get home visits, 
you would omit that category from consideration and assess the individual based on the 
other three). 
 
1 – Non-Adherent:  Successful at 0% of recommended care plan categories 
 
3 – Mildly Adherent:  Successful at 30 – 50 % of recommended care plan categories 
 
5 – Moderately Adherent:  Successful at 60 – 90% of recommended care plan categories 
  
7 – Highly Adherent:  Successful at 100% of recommended care plan categories 
 
 
This participant’s adherence rating is: 
 
1              2            3         4      5          6      7 
 
 
Of the above categories: 
What is this participant most successful with:________________________________ 
 
What is this participant least successful with:________________________________ 
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